ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001193.1|Thiolutin_1 # 3 # 5129 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.773	BGC0001193.1|Thiolutin_1 	3	5129	+	Loose	1000	130.183	almE	27.47	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GGGCTGACCGCCTGGCGCGAGGCCCTGGCCGGGCTGGAGGAGGGCACGCGGCTGGCCCGCGAGTCCTCGGTGGTGGACCGCCCCGAGCGGGTCACCGTCGGCCTGGGCGCGGAGTTCAGCGACCGGCTGCGCGCGTTCGCCCGGTCCCGCGGGGTCACCACGACCACCGTGCTCCAGACCGCGTGGGGCGTGCTGCTGGGCCGGCTCACCGGCCGCCGCGACGTCGTCTTCGGCTGCCCGGTCTCCGGCCGCCCCGCCGAGGTCGACGGCGTCGAGTCGATGATCGGCCAGCTCGGCAACACCATCCCCGTCCGGGTGCGCCACACCGCCGCCGACACCGCCGCGGACCTGCTCGACCGCGTGCACGCCGAGAGCGTCGCCCTGGCCGAGCACCACCACGTCGGCCTGCCCGACATCCAGCGCGCGGCCGGCCTGGGCGAGCTGTTCGACACCATGCTGGTGATGGAGAACTTCCCGCTCTCCAGCCGCCACCGCGTCACCCTCGCGCCCGGCCTCGACCTGGTCGGCGTCGACATCACCGACGCCACCCACTACCCGCTGACGGTGATCGTCCTGCCCGACGAGGAGATCACCCTCGGCCTGGGCTACCAGCCGCAGGTGCTCGACGAGGCCACCGTGCGCGGCTACGGCCGCTGGCTGCGCACCCTGCTGCACGAGATCGTCGACGACCCCGACCGCCCGGTCGCCCGGCTGCGCGCCCTCGACGCCCGCGAGCAGGACGACCTGCTGCGCCTGGGCGCCGGGCCGCGGCCGAAGCGGGCGCGCGGCGACGTGCTGGCGGAGTTCGGCCGGTGGGTCGCCGACACCCCCGACGCCGAGGCCGTGGTCTGCCGCGACCGCTCGCTGACCTACGCCGAGCTGGACCGGCGCGCCAACCGCCTGGCCAACGCCCTGCTGGCCCGCGGCGTCCGCCCGCAGGACCCGGTGGCGGTGCTGCTGGGCCGTGACGTGGAGCTGGTCGTCGCCCTGTTCGCCGTGCTCAAGGCGGGCGCGGTGCACGTGCCGATGGACCCCGACTACCCGCGCGACCGGCTGGCCTACATGGCCGAGGACATCGCGCCCGCCGCGGTGATCGCGCAGTCCCACCCGGGCTTCGGCGACCAGCCGCTGGTGCGGCCCGACGCCGACGCGCCCTCCGACGACGACCCGGTGCACGCGCGGGCCGGGCTGACCCCCGACTCGCTGGCCTACGTCATCTACACCTCCGGCACGACCGGCAAGCCCAAGGGCGTCGCCGTGCCGCTGCGCGGCCTGCCGAGCCTGATCGCGCTGCAGGAGGACGTCGTCGGCATCGGCGGGCGCGAGCGGTACCTGCACTTCGCCTCCACCAGCTTCGACGTGGCGTTCTGGCAGTTCATGCTGCCGCTGCTGTCGGGCGGCACGTCGGTCATCGCGCCCGAGGAGGTGCGCGTGCCCGGCGACGAGCTGCTGGACTACATCGCCGAGCACCGCGTGACGGGCGTGAACCTGCTGCCGTCGTTCCTGGCGGCCATGCCCGACGACCGGACCGTGCCGCCGGAGGTGTTCTTCGTCGTCGGCGCCGAGCGCCTCGACCCGGAGCTGGCGCGCCGCTGGGGCGACCGGCGGGCGCTGTTCAACGCCTACGGGCCCACCGAGGTCACCATCAACTCCGTCACCTGGCACTACGCCCCCGACGACCCGGGACCGCTGCCGATCGGCCGCCCCGACCCCGAGGTGCGCGCCTACGTGCTCGACGGCGGCCTGCTGCCGGTCGGCGTCGGCGTGACCGGCGAGCTGTACCTGGCGGGCCCGAAGCTGGCCCGCGGCTACGTCAACCGGCCGGGCCTGACCGCGGAGCGGTTCGTGGCCGACCCGTTCGGCGCGCCCGGCGAGCGCATGTACCGCACCGGGGACCTGGTGCGGTGGCGGCCGGACGGGCAGCTGGTGTTCCTCGGGCGGGCCGACCACCAGGTCAAGGTGCGCGGGTTCCGCATCGAACTGGCCGAGGTCGAGACGGTGCTGTCGCGGCACCCCGGCGTGCGGGCGTGCGCGGTGATCGTGCGCGAGGGCCGGCTCGTCGGCTACGTCATCCCGGCCACCGCCACGACCGACACCGCCGCCACTCCCGGCACCGCTGCCGCCCCCGACAGCGCCGCCGCCCCCGACAGCGCCGCCGCCCCCGACAGCGCCGCCACTCCCGGCACCGCTGCCACGACCACCGCGGTTGCCGCCGGGTTGGACCTCGCCGACGTGCGCGCCCACCTGGCCGCCGAGCTGCCCGACCACATGGTGCCCGCCGCGCTGGTGGTGCTCGACCGCCTGCCGCTGGGCCCCACCGGCAAGCTCGACCGGGCCGCGCTGCCCGCGCCCGAGGTGCGCGCCGCCGCCGCCCGCGAACCGGCCACGCCGACCGAGGCCGTGCTGCTGGAGGTCTTCCGCGAGGTGCTGGGCCGCGCGGACGTGCAGCTCGACGACGCGTTCCTGGACGTCGGCGGCGACAGCATCGTGTCGCTGCGCCTGGTGTCCCGGGCCCGCCGGGAGGGCCTGACGCTGACCGCGCGGGACGTGTTCGAGGGCGCCACCGTCGCGGGCATCGCCGCCCGCTGCGGCGCGGCCGAGGAGCCCGAGGCCGCGCCGGCGGTCGGCGACGCGCCGCTCACGCCGGTGATGCGGGACCTGCTGCTCCGCTGCGCGGCCGGCGGCGCCTCCGCCGACAGCTTCTGCCAGTGGGTCGAGGTGTGCGTGCCGCCGGGCTCGGTCGACACCTGGCGGCGGGTCCTGGACGCCGTGTTGGCCCGCCACGACGTGCTGCGCGCCCACCTGGCCGACACCGGCGCCGACGGCCCCGTGCTGCGCATCCCCGAGGTGGGCGCGGTGACCGCCGCCGACGTGCTGGTGCACGTGCCGGCGACCGGCGACCTGCGCGCCCTGGCCGACCGGCACGTCGCCGAGGCCCGCGCCCGCATGGACCTGCGCACCGGGCCGCTGCTGCGCGCCGTGTGGCTCGACGCGGGGGAGCGGCCGGGCCGGCTGGTGCTGGTGGGCCACCACGTCGTCGTGGACGCGGTGTCCTGGCGCGTGCTGCTCGACGACGTCGAGCACGCCCACGCCGGCCACCCGCTGCGCCGCCACGGCCAGTCCTTCCTCGGGTGGGCCCGGTCCCGCCGCGACCACCGGCCGGTCCTGGTCGCGGACGTCCCGCCGCCGCTGGCCCGCACGCCGCTGGACCCCGCGCGCGACACCACGGCCACGGCCGTGCACCACGTGGTGCACCTCGACCCGGAGACGACCAGGACCCTGCTCACCACCCTGCCCGCCGCCTACCGCACCACCCCGGACACCGTCCTGCTGACCGCCCTGGCCCGCGCGGCGGCCCGGTGGCGCGGCGGCGCGGCGGACCTCCTCGTCGCCCTGGAGAGCCACGGCCGCACCGACGAGCTGTCGCAGACCGTCGGCTGGTTCACCGCCGTGCACACCGCCCGGGTCACCCCGGCCGGCACGGCGTCCGCCGCGCTCAAGGCGGTCAAGGAGCAGCTCCCGCGCGCGGTGGCCGCGACGCCGGAGGTCTCCTGGAACTACCTGGGCCGCTTCCCCGCCGCCCCGACCGCGGAGGTCCCCTGGCAGGCCCCGCCGGACGCCGACCCGCTGGGGTCCGGCGGCGACGACCTGCCGCTGCCCCACGCGCTGATGGTCAACGCCCTGGAGCGCGACGACCGGCTCGGCGTCCGCTTCACCTGGCCCGGGGCCCTGTTCGACGCCGAGGAGGTCGCCGAGCTGGCCGAGCACCTGCGCCGCGCGGCGACCGACCTCGCCGCCGACCCCGACGCGCGCGAGCGCGCCGGGCTCACCCCGTCCGACCTGCCGCTGGTGGACCTCGACCAGGCCGCGATCGAGCGGCTGGAGGGCGACCGCGCCGTGGCCGACGTCCTGCCGCTCACGCCGCTGCAGGAGGTGGTGCTGCGGCACGCCGAGGTCTACCCCGTGCAGGCCGCGTTCACGGTGGCCGGCGCGCTGGACGTGCCGGCGCTGCACGCCGCCGGCGCGGACCTGCTGCGCCGCCACCCCAACCTGGGCGCGGTGTTCCCGCCCGACCTGCCCGTGCAGGTGGTGCCCGTCGACCCGCGGCCGGACTGCCGCCTGGCCGAGGTGGCCGACGTCGAGCAGGCGCTGGCCGACGACCTCGCCGAGCCGTTCGACCCGGCCACCGGCCCGCTGGTGCGCCTGTCGGTCCTGCGGCACGGCGCCGAGCAGGTCGTCGTGCTGACCACCCACCACGTGCTGTCCGACGGGTGGTCCGCGCCGCGCATCCTCACCGAGCTGTTCGCCCTCTACGCCGCGCGGGTCGCGGGCGTCGCGCCGGACCTGCCCGCGCCCGTCCCGTTCGCCCGCTACCTGCGCTGGCGCGCCGGGCGGGACCACGACGCCGACGTGCGGGCGTGGCGGGAGGAGGTCGCCGGCCTGCCCGAGGGCGACTACCTCACCCGCGGCAGGCCCACCCCGGTCGGCCCGGTGGACCCGGTGCTGTTCGCGGTCGGGCCGGACGTGGTCGCCGGGCTCACCCGCGCCGCCGCGCGCCGCGGCCTGACGCCCAACACGCTGCTGCAGGGCGCGTGGGCGACGGTGCTGGCCGCCCGCTCGGGCCGCGCGGAGGTGTGCTTCGGCGCGATGGTGTCCGGGCGGCAGGCCGACGTGGAGGGCGTGGAGGACATCCTCGGCCTGCTCGCCGGCACGGTGCCCGTGCGCGTCCGCCTCACCGGTGTCCTGGGCGACGCGCTCGCCGACCTCCAGGCCCGCCAGCAGAACCAGGCCGTCCACGTGGGACTGTCCGAAATAGAGGGTGATCGCGTGCGGCTGTTCGACAGCCTCGTGGTGTTCGAGAACTACCCCGTGGACCCCGAGCGGCTGCGCGAGCCCGCGCCCGGCCTGACCGTCACCGCCGCCCGGTTCCGCGAGCGCACCCACCACCCGGTCACGCTCACCGTCGTCCCGGAGGGCGGCGGCTGGACCGGTGTCCTGGGCTGCCTGCGGGGGGTGTTCACCGCCGCCGAGGAGCGCGCGCTCGCCGACGACCTGCTGGCCGCCCTGCGCGACCTGCCCGCCGGCCTCGACGCCGACGCGGGCGACTTCCTCGCGGGCCGCTCGTGA	GLTAWREALAGLEEGTRLARESSVVDRPERVTVGLGAEFSDRLRAFARSRGVTTTTVLQTAWGVLLGRLTGRRDVVFGCPVSGRPAEVDGVESMIGQLGNTIPVRVRHTAADTAADLLDRVHAESVALAEHHHVGLPDIQRAAGLGELFDTMLVMENFPLSSRHRVTLAPGLDLVGVDITDATHYPLTVIVLPDEEITLGLGYQPQVLDEATVRGYGRWLRTLLHEIVDDPDRPVARLRALDAREQDDLLRLGAGPRPKRARGDVLAEFGRWVADTPDAEAVVCRDRSLTYAELDRRANRLANALLARGVRPQDPVAVLLGRDVELVVALFAVLKAGAVHVPMDPDYPRDRLAYMAEDIAPAAVIAQSHPGFGDQPLVRPDADAPSDDDPVHARAGLTPDSLAYVIYTSGTTGKPKGVAVPLRGLPSLIALQEDVVGIGGRERYLHFASTSFDVAFWQFMLPLLSGGTSVIAPEEVRVPGDELLDYIAEHRVTGVNLLPSFLAAMPDDRTVPPEVFFVVGAERLDPELARRWGDRRALFNAYGPTEVTINSVTWHYAPDDPGPLPIGRPDPEVRAYVLDGGLLPVGVGVTGELYLAGPKLARGYVNRPGLTAERFVADPFGAPGERMYRTGDLVRWRPDGQLVFLGRADHQVKVRGFRIELAEVETVLSRHPGVRACAVIVREGRLVGYVIPATATTDTAATPGTAAAPDSAAAPDSAAAPDSAATPGTAATTTAVAAGLDLADVRAHLAAELPDHMVPAALVVLDRLPLGPTGKLDRAALPAPEVRAAAAREPATPTEAVLLEVFREVLGRADVQLDDAFLDVGGDSIVSLRLVSRARREGLTLTARDVFEGATVAGIAARCGAAEEPEAAPAVGDAPLTPVMRDLLLRCAAGGASADSFCQWVEVCVPPGSVDTWRRVLDAVLARHDVLRAHLADTGADGPVLRIPEVGAVTAADVLVHVPATGDLRALADRHVAEARARMDLRTGPLLRAVWLDAGERPGRLVLVGHHVVVDAVSWRVLLDDVEHAHAGHPLRRHGQSFLGWARSRRDHRPVLVADVPPPLARTPLDPARDTTATAVHHVVHLDPETTRTLLTTLPAAYRTTPDTVLLTALARAAARWRGGAADLLVALESHGRTDELSQTVGWFTAVHTARVTPAGTASAALKAVKEQLPRAVAATPEVSWNYLGRFPAAPTAEVPWQAPPDADPLGSGGDDLPLPHALMVNALERDDRLGVRFTWPGALFDAEEVAELAEHLRRAATDLAADPDARERAGLTPSDLPLVDLDQAAIERLEGDRAVADVLPLTPLQEVVLRHAEVYPVQAAFTVAGALDVPALHAAGADLLRRHPNLGAVFPPDLPVQVVPVDPRPDCRLAEVADVEQALADDLAEPFDPATGPLVRLSVLRHGAEQVVVLTTHHVLSDGWSAPRILTELFALYAARVAGVAPDLPAPVPFARYLRWRAGRDHDADVRAWREEVAGLPEGDYLTRGRPTPVGPVDPVLFAVGPDVVAGLTRAAARRGLTPNTLLQGAWATVLAARSGRAEVCFGAMVSGRQADVEGVEDILGLLAGTVPVRVRLTGVLGDALADLQARQQNQAVHVGLSEIEGDRVRLFDSLVVFENYPVDPERLREPAPGLTVTAARFRERTHHPVTLTVVPEGGGWTGVLGCLRGVFTAAEERALADDLLAALRDLPAGLDADAGDFLAGRS	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	307.19	gnl|BL_ORD_ID|4935|hsp_num:0	5928			135	1494	colistin A; colistin B
BGC0001193.1|Thiolutin_2 # 5126 # 6523 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=6bp;gc_cont=0.775	BGC0001193.1|Thiolutin_2 	5126	6523	+	Loose	950	147.517	tcr3	33.41	3002893	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGACCGCCCCCGTGGTCGACCGCTCCCTGTGGCGGGCCGCGTTCGTGCTCGTCCTGGGCACGTTCATGGCCACGCTCGACAGCACGATCGTCTCCGTCGGCCTGGACGCGCTCGCCGAGCGGTTCCACGCGCCGGTCACCGAGGTCCAGTGGGTCGGCACCGCCTACCTGCTGGCCGTGGTCGCGGCCGTGCCCGCGTCCGGGTGGCTGGCCGACCGGTTCGGCGGGCGGCGGGTGTGGCTGTGCGCGGTCGCGCTGTTCCTGCTCGGCTCGCTGCTGTGCGCGGTGGCGTGGTCGCTGCCCAGCCTGGTGGTGTTCCGGGTCGTGCAGGGCCTGGGCGGCGGCCTGCTGCCGGCGACCGGGCAGGCGCTGCTGGCGCGGGCCGCCGGGCGCGAGCGCATCGGCCGGCTCATCGGCGTGGTCGGCGTCGTGCCGCTGCTCTCGCCGGTGCTCGGGCCGCTGGTGGGCGGCGCGATCCTGGGCGTCGCCGACTGGCCGTGGCTGTTCCTGGTCAACCTGCCCGTCGGGCTCGGCGCGCTGCTGCTGGCCCGCCGGCACGTGCCCGCGGCGCCGCCGGCCGAGCGGCCCGGCGCGTTCGACGTGCGCGGCGCGCTGCTGCTCTCGCCCGGCCTGGCCGTCCTGGTGTACGGGCTGTCGGGCTTCGGCCACGGCCCCGCGCTCACCCCGGCGCTGGTCGTCGCGGTCGGGGCGGGGGCGCTGGTGGCGTTCGTCGTCCACGGCCTGCGCACCACCCGCGTCCCGCTGATCGACCCGCGCCTGTTCGCCCGGCCGCCGTTCGGGGCGGCGGCGCTCGCGCTGGCCCTGCTCGGCGCGTCGGTGTTCGGCACGATGTTCCTGCTGCCGCTGTACCTGCAGACCGACCTGACGGCGTGGCAGGCGGGCCTGCTGCTCGCGCCGCAGGGCGTCGGCGCCGCGCTCGGCTCGGTGCTGGTGACCCGGGTCGTGGACGCCGCCGCCCCGCGCACCCTCGTGCTGGCCGGCATCGGGCTCGTCGCCGCGGGCACGGCGCCCCTGACCCTGCTCGGGCACGACCTGCCCGACGCCGTGATCGTGTTCGCGCTGCTGGCGCGGGGCACCGGCGCGGCGCTGGTCGGCGCACCCGTGATGGCGCTGGTCTACCGGGCGGTCGAACCCGCCCGCCTGCCGCGCGCCGCCGGTGCGCTGAACCTGCTCAACACCGTCGGCGGTTCCGTCGGCACCGCGCTGCTCGCCGTCGTGCTCCAGAGCCGGCTGGCCGCTCGCGGCGCCGACCCCTCCGCCGTCTCCGCCGCGTTCGCCGACACCTTCTGGTGGGTGCTCGGCCTGGTCCTCGTCGCGGCCGCCGCAGCGACCAGGCTGCCCCGCCCCGACAACGAGAAGGGCACTGCCGATGCTTGA	MTAPVVDRSLWRAAFVLVLGTFMATLDSTIVSVGLDALAERFHAPVTEVQWVGTAYLLAVVAAVPASGWLADRFGGRRVWLCAVALFLLGSLLCAVAWSLPSLVVFRVVQGLGGGLLPATGQALLARAAGRERIGRLIGVVGVVPLLSPVLGPLVGGAILGVADWPWLFLVNLPVGLGALLLARRHVPAAPPAERPGAFDVRGALLLSPGLAVLVYGLSGFGHGPALTPALVVAVGAGALVAFVVHGLRTTRVPLIDPRLFARPPFGAAALALALLGASVFGTMFLLPLYLQTDLTAWQAGLLLAPQGVGAALGSVLVTRVVDAAAPRTLVLAGIGLVAAGTAPLTLLGHDLPDAVIVFALLARGTGAALVGAPVMALVYRAVEPARLPRAAGALNLLNTVGGSVGTALLAVVLQSRLAARGADPSAVSAAFADTFWWVLGLVLVAAAAATRLPRPDNEKGTADA	MGMANATSQTGEAVADEAGGPAGFTHRQIITALSGLLLAVLLAALDQTIVSTALRTIGDQLHGQTVQAWVITGYLVSSTIAMPFYGKLSDIYGRKPLYLAAIAVFIVGSAACAMANSMETLAIARVLQGFGGAGLMSLPTAVIADLAPVRERGRYFSYLMMAWVAASVLGPLVGGLFAGAGEILGVTGWRWAFLINVPLGLVALLSVRKALNLPHRRVDHPIDFRGALTLALCLVPLLIVAEEGLDWGWGSARSLTLFAVSLIGLVLFVLAERARGLEAMVPLRLFRRGGITMATAVNFTIGVGIFGTVSTLPLFLQLVQGRSATVAGLVIIPVMTGAIVSQTICAKIIKKWNRYKKPAIVGLGSMAGALLSLSAAGADTPLAVIVVIAAWLGFGIGLSQTVITLAIQSSAPKSELGVANAASGLFRQLGGTSGAAVFMSVLFGVAAGRLDGADPDEAVRRALSDPGSTGGLSASAVDAFTSGFDTMFLVGGLILAVGFLLTFPLRELRDEE	90.82	gnl|BL_ORD_ID|592|hsp_num:0	652			135	1395	tetracycline
BGC0001193.1|Thiolutin_3 # 6516 # 7544 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGG;rbs_spacer=8bp;gc_cont=0.764	BGC0001193.1|Thiolutin_3 	6516	7544	+	Loose	500	25.7942	tet(C)	34.15	3000167	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCTTGACACCCTGCCCACACCCGCCGACGTGGCCGCAGCGCACCCGCTGCCGGCCACCGCCGCCGACGACATCGCCCGGCACCGCAACACCGTCGCCGACGTGCTGGCCGGGCGCGACCCCCGACTGCTCGTCGTGGTCGGGCCGTGCTCCGTGCACGACCCGCTCGCCGCCCTGGAGTACGCGCGCCTGCTCGCCGCCGAGGCGAGCCGGCTCGCCGACGACCTCGTGGTCGTGCTGCGGGCCTACCTGGAGAAGCCGCGCACCGTCTCGGGGTGGACCGGCCTGCTCACCGACCCCGCGCTGGAGGGCAAGGGCGACATCGCGACCGGCCTGCAGGTGGGCCGGGCGTTCCTGGTGGAGGCGGCGGCGCTGGGGCTGCCGCTGGCCTACGAGTTCGTGGACCCGATGCTGGCCCACCACGTCGCCGACACCGTGAGCTGGGGCGCGGTGGGGGCGCGCACGGTGGCCGCGCAGCCGCACCGGCACCTGGCGTCGTGGCTGCCGATGCCGGTGGGGCTGAAGAACTGCGTCACCGGCCACCTGGGCACCGCCATCGACGCGATCCGGGCGTCCCGGCTGCCGCACACCTTCCCCGGCGTCGGCCTCGACGGGCGCCTCACCACGCTGCGCAGCACCGGCAACCCGGACACCCACCTGGTCCTGCGCGGCGGCCGGGAGCCCAACTACGGGGCCGCGCACGTGTCGGCCGCCCTCGACGCCCTGAACGCGGCCGGCCTGCCGCCGCGGGTGGTCGTGGACGCCTCGCACGGCAACAGCGGCAAGGACCACAACCGCCAGCCCGGCGTGGTCGAGGACCTGGCCGGCCAGATCGCGGCGGGCAACCGCCGGCTGACCGGGGTGATGATCGAGTCCTACCTGTCCGACGGCAACCAGAAGGCGCCCCGGCGCCCGGACGTGAGCCTGACCGACGCGTGCCTGGGCTGGGCCCGCACCACGCCGCTGCTGGAGGTCCTGGCCCGCGCCGTCCGGGCGCGGACGGCGGTGCCCAGCGCGGCGACGGTCTGA	MLDTLPTPADVAAAHPLPATAADDIARHRNTVADVLAGRDPRLLVVVGPCSVHDPLAALEYARLLAAEASRLADDLVVVLRAYLEKPRTVSGWTGLLTDPALEGKGDIATGLQVGRAFLVEAAALGLPLAYEFVDPMLAHHVADTVSWGAVGARTVAAQPHRHLASWLPMPVGLKNCVTGHLGTAIDAIRASRLPHTFPGVGLDGRLTTLRSTGNPDTHLVLRGGREPNYGAAHVSAALDALNAAGLPPRVVVDASHGNSGKDHNRQPGVVEDLAGQIAAGNRRLTGVMIESYLSDGNQKAPRRPDVSLTDACLGWARTTPLLEVLARAVRARTAVPSAATV	MKSNNALIVILGTVTLDAVGIGLVMPVLPGLLRDIVHSDSIASHYGVLLALYALMQFLCAPVLGALSDRFGRRPVLLASLLGATIDYAIMATTPVLWILYAGRIVAGITGATGAVAGAYIADITDGEDRARHFGLMSACFGVGMVAGPVAGGLLGAISLHAPFLAAAVLNGLNLLLGCFLMQESHKGERRPMPLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPAALWVIFGEDRFRWSATMIGLSLAVFGILHALAQAFVTGPATKRFGEKQAIIAGMAADALGYVLLAFATRGWMAFPIMILLASGGIGMPALQAMLSRQVDDDHQGQLQGSLAALTSLTSIIGPLIVTAIYAASASTWNGLAWIVGAALYLVCLPALRRGAWSRATST	86.36	gnl|BL_ORD_ID|892|hsp_num:0	900			300	423	tetracycline
BGC0001193.1|Thiolutin_4 # 7586 # 9277 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGAGGG;rbs_spacer=14bp;gc_cont=0.768	BGC0001193.1|Thiolutin_4 	7586	9277	+	Loose	700	30.4166	ACC-2	19.83	3001816	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	ACC beta-lactamase	GTGGCGGCGGGGCGGCGGCCCGTCGAGCGGTCCGGGAGGGGACCGCTCGACGGGCCGCGCGGCCCGCGCGAACCGGCGGACCCGGGGCCGCGCGCGGGGAAGCGGCCGGGCGCGGGGGCGGCTCGGTGTACGGTTCCCGCCGTGGAGCGCTCGATCTTCCCGACCGGCAGCCGGAACCGATCCCTGACCAGCCTGCGCGCGCCCGGCGCCGAGCCGGACGGGAGCGCCCCGGCCGACCAGGCCCCGCCGCCCGCCGCCCCGGTCCCGCCGGCCGACACCCCGGCCGACACCCCGGACGACCTGGAGGCCGCCGTCGAGCGCGCCTACCGGCTGATCCTCGGCCGGCCGGCCGACCCGGAGGGCCTCTCCCGGTACGTGGCGGGGCTGCGCTCCGGCGAGGTCGCGCTGCCCGACGTCTGCGCCGGCCTGGCGGCCTCCGAGGAGTTCGCCCGGCGGCTGACCCCGCCGCCCGCGCCGACCGCCGCCGACACCCGCCCCGAGGACGACCCGGACTGGGTCGACGTGGCGGAGCTGATCAGGACGGTGACCGTGGAGGAGCTGGCCGAGCGCGCCGAGGGCTACTTCCGGGCGGTGGAGGACCCCGAGCTGCTGCTGACCAAGCCGGCCAAGGACCCGACCGACGCGCCCGACCTGCTGGTCACCTTCGGCCAGGTGCTGCGCGGCCTGCGCCCGCAGCCGGGCATGACGGTCCTGGACTTCGGCGCCGGCACCTGCTGGACCAGCCGCTTCCTGACCCAGCTCGGGTGCCGCGTGATCGCGCTGGACGTCTCGCCGACGGCGCTGGAGCTGGGCAGGCGGCTGTTCGAGGTCCAGCCCGTGCTGGGCGACCAGCCCGAGCCGGACTTCCTCGTCTTCGACGGCCACCGCATCGACCTGCCCGACGCGAGCGTGGACCGCGTCCTGTCCTTCGACGCCTTCCACCACGTGCCCAACCCCGACGAGGTGATCCGCGAGATGGCGCGGGTGCTGCGCCCCGGCGGCATCGCGGCGTTCTCCGAGCCCGGCGACCGCCACTCGGTCCAGGCGCAGTCGCAGTTCGAGATGCGCAACTACGGGATCATCGAGAACGACGTCCTGATCGACGAGGTCTGGGCGTGGGCGCGGGAGGCCGGGTTCGCCGAGCTGCGGCTGTGCCTGTTCGACTCCGCGCCCCGCTGGGTGGACGTCGAGACCTTCCACGACGTGGTCGCCGGGCAGGAGGCCGGCCAGGACGTGTTCTCCGCGCCCACCCGCGCGGCGATCGGCGACCGACGCCTGTTCGTGCTGCGCCGCGAGGGCGAGGCGGCGCTGGACAGCCGCGAGGCCAGGGGCCTGGTCGCCGAACTGGCGCTGGACGACGTCGAGGTCGACCGGTCGGGCGAGGTGGTCGTCGTGACCGGCTCCTGCCGCGTGCGCAACCCCGGCCCCCGGACCTGGCTGCCCTCCGACGCCCGCTTCGGCCCCGTGCTGCTCGGCGTCCGGCTCCACCTGGCCGACCGCACCACGCGCGATCTGACCCGGGTCCCGCTGCCGGGGCGCGGCGTCGAGCCGGGCGGGAGCGCCGGGTTCCCGGTGCGGGTCGAGGTGCCGCCCCAGCCCGAGGGCGTCGTGGCGGTGGAGTTCGACCTGGTCAGCGAGCGGGTGTGCTGGTTCGGCGCCAACGGCTCGCCGGTGGTCAGGCTCGCGCTGTGA	MAAGRRPVERSGRGPLDGPRGPREPADPGPRAGKRPGAGAARCTVPAVERSIFPTGSRNRSLTSLRAPGAEPDGSAPADQAPPPAAPVPPADTPADTPDDLEAAVERAYRLILGRPADPEGLSRYVAGLRSGEVALPDVCAGLAASEEFARRLTPPPAPTAADTRPEDDPDWVDVAELIRTVTVEELAERAEGYFRAVEDPELLLTKPAKDPTDAPDLLVTFGQVLRGLRPQPGMTVLDFGAGTCWTSRFLTQLGCRVIALDVSPTALELGRRLFEVQPVLGDQPEPDFLVFDGHRIDLPDASVDRVLSFDAFHHVPNPDEVIREMARVLRPGGIAAFSEPGDRHSVQAQSQFEMRNYGIIENDVLIDEVWAWAREAGFAELRLCLFDSAPRWVDVETFHDVVAGQEAGQDVFSAPTRAAIGDRRLFVLRREGEAALDSREARGLVAELALDDVEVDRSGEVVVVTGSCRVRNPGPRTWLPSDARFGPVLLGVRLHLADRTTRDLTRVPLPGRGVEPGGSAGFPVRVEVPPQPEGVVAVEFDLVSERVCWFGANGSPVVRLAL	MRKKMQNTLKLLSVITCLAATAQGAMAANIDESKIKDTVDGLIQPLMQKNNIPGMSVAVTIRGRNYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAAILASYAQASGKLSLEQSVSHYVPELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMTYLKAWKPADAAGTHRVYSNIGTGLLGMIAAKSLGVSYEDAIEQTILPLLGMNQTYLKVPADQMENYAWGYNKKDEPVHVNMEILGNEAYGIKTTSSDLLRYVQANMGQLKLDGNAKIQHALTATHTGYFKSGEITQDLMWEQLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVMLANKNYSIDQRVTVAYKILSSLEVNK	144.36	gnl|BL_ORD_ID|1864|hsp_num:0	2024			210	558	
BGC0001193.1|Thiolutin_5 # 9461 # 10681 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=6bp;gc_cont=0.765	BGC0001193.1|Thiolutin_5 	9461	10681	-	Loose	500	26.5646	CARB-4	29.31	3002243	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CARB beta-lactamase	ATGACGAACCCGTCGCAGCCCGTCGGCGAGGGCACGGCCCGCCTCCCCCGGTACCCGATGCCCCGCGCCGACGGCTGCCCGTTCGACCCGCCGCCCGCCCTGCGCGGGCTCCGGGAGCGGGCGCCGTTGGCGAAGGTCGAGCTGTGGGACGGCAGCACGCCGTGGCTGGTCACCCGCTACGCCGACCAGCGCGCCGTGCTCGCCGACCCCCGCGTGAGCGCCGACATGGCGCACCCCGCCTACCCGCTGCAGGGTCCGGGCACCGGCTCGCTGAGCCTGGTCGGCATGGACGACCCCGAGCACGCCCGGCTGCGGCGCATGGTCAACGCCGCGTTCACGGTGAAGAAGGTCGAGGCCCTGCGCCCGGTCGTGCAGCGGGTCGTGGACGACGCGGTCGACGCGCTGTCGGCCGGTCCCCGGCCGGTGGACCTCGTGGAGGCGTTCGCGCTGCCCGTCCCGTCGCTGGTGATCTGCGACCTGCTCGGCGTGCCCTACGCCGACCACGGCTTCTTCCAGGCGCGCAGCCGGACCCTGGTCCACCGGGGCTCCACCGGCGAGCAGCGCGCGGCGGCGATCGCCGACCTGGGCCGGTACCTGGCCGGGCTGCTGGCCGACCGGGTCGACCGCCCCGGCGACGACCTGCTGTCCCGGCTGGGCGAGCGGGTCGCCGCCGGCGAGCTGGGCGCCGGGCAGGCCGCCGAGCTGGCCGTGCTGCTGCTGCTCGCGGGCCACGAGACCACCGCCAACATGATCGCGCTGGGCACCCTGCTGCTCCTGCGCCACCCCGACCAGCTCGCGCTGCTGCGCGACCGCGATGACCCGGCCACCACCGCCCGCGCGGTGGAGGAGCTGCTGCGCTACCTCACCATCACCCACGGCGGGCGCCGCCGCTTCGCGCTGGCGGACCTGGAGGTCGGCGGGCAGCTCGTGCGGGCGGGCGAGGGCCTGGTGCTGCCCACCGACGTCGGCAACCGCGACCCCGCCGCCTTCCCCGACCCGGACCGGCTCGACCTGACCCGCGAGGCCCGCCACCACCTCGCGTTCGGGTTCGGCGCGCACCAGTGCCTGGGCCAGTCGCTGGCCCGGCTGGAGCTGGAGGTGGCCTACCGCACCCTGCTGCGCCGCGTGCCCGGCCTGCGCTCGGCCGTCGACCTCGACCGGATCCCGTTCAAGCACGACGGGTTCGTCTACGGCGTGCACGAGCTGCCCGTGACCTGGTAG	MTNPSQPVGEGTARLPRYPMPRADGCPFDPPPALRGLRERAPLAKVELWDGSTPWLVTRYADQRAVLADPRVSADMAHPAYPLQGPGTGSLSLVGMDDPEHARLRRMVNAAFTVKKVEALRPVVQRVVDDAVDALSAGPRPVDLVEAFALPVPSLVICDLLGVPYADHGFFQARSRTLVHRGSTGEQRAAAIADLGRYLAGLLADRVDRPGDDLLSRLGERVAAGELGAGQAAELAVLLLLAGHETTANMIALGTLLLLRHPDQLALLRDRDDPATTARAVEELLRYLTITHGGRRRFALADLEVGGQLVRAGEGLVLPTDVGNRDPAAFPDPDRLDLTREARHHLAFGFGAHQCLGQSLARLELEVAYRTLLRRVPGLRSAVDLDRIPFKHDGFVYGVHELPVTW	MKLLLVFSLLIPSMVFANSSKFQQVEQDAKVIEASLSAHIGISVLDTQTGEYWDYNGNQRFPLTSTFKTIACAKLLYDAEQGEINPKSTIEIKKADLVTYSPVIEKQVGQAITLDDACFATMTTSDNAAANIILNALGGPESVTDFLRQIGDKETRLDRIEPELNEGKLGDLRDTTTPNAIVNTLNELLFGSTLSQDGQKKLEYWMVNNQVTGNLLRSVLPEGWNIADRSGAGGFGARSITAVVWSEAQSPIIVSIYLAQTEASIADRNDAIVKIGRSIFEVYSSQSR	140.97	gnl|BL_ORD_ID|90|hsp_num:0	105			501	663	
BGC0001193.1|Thiolutin_6 # 10714 # 11886 # -1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=13bp;gc_cont=0.772	BGC0001193.1|Thiolutin_6 	10714	11886	-	Loose	800	26.9498	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid	24.86	3003461	protein variant model	T110A	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant ndh	GTGCTGGTCGTCGGCGCCTCCGCCGCCGGGCTGGCCACGGTCGAAGCACTGCGCCGCAAGGGCTACACCGGCGAGGTGACCCTGCTGGGCGACGAGGGGCACCCGCCCTACGACCGGCCGCCGCTGTCCAAGCAGGTGCTGTCCGGCCGGTGGGAGCCCGACCGGGCGCACCTGCGCACCGCCGAGGCGCTGGAGGCGCTGCGCGCCCGCCTGGTGCTGGGCGACGCGGCGGTGTCGCTCGACGTCGGGGCGCGGGCGGTGCGCACCGCCTCGGGCGCCACGCTGACCGCCGACACCGTGGTGGTGGCGACCGGGGCGCGGCCCCGGACCCTGGGCGGCGGGCCGCGGGTGGCCGGCGTGCACGTGCTGCGCACGGTGGCCGACGCGCTCGTGCTGCGCGCCGACCTGGTGGCCGCGCGGCGGCTGGTGGTGGTCGGCGACGGCGTGCTGGGCACCGAGATCGCCGCCACCGCGCGCGAACTCGGCGTGGACGTCACCGTCCTGGGGCTCCAGCCCTCGCTGATGGCGTTCCCGCTCGGGCCGCTGGCCTCCGGGGCGCTGACCGCGCTGCACGTCGAGCGCGGTGTCCGGCTGCGGCCGGGCACCGCGTTCGACGGCCTGGTCGACGACGGCGACCGGGTCACCGGCGTGCGGGTGGCGGGCGGCGAGGTGCTCCCGGCGGACGTGGTCGTGGTCGCGGTGGGCGCGGTCCCGAACACGGAGTGGTTGGCCGACAGCGGGTTGGCGCTGGACAACGGCGTGGTGTGCGACGAGCGGTGCCGCGCCGCCGAGGGCGTCTACGCGGTCGGCGACGTCGCCCGCTGGCAGCACCCCCGCCTGGGGTCGCTGCGGCTGGAGAACCGCACGAACGCCACCGAGCAGGCCGCGGCGGTGGCGGAGGACATCCTGGGCGCGGACCGGCCCTACGCGCCCGTGCCGTACTTCTGGACCGACCAGTTCGACGCGAAGATCCACGTCCACGGCGTGCCCACCGCGGGCACGCGGGTGACCGTGGTGGAGGGCGAGGTCGCCGACCGCCGCTTCGTGGCGCTGTACGAGCAGGACGACGGCGAGGCGGTCGGCGTCCTGGGCTGGAACATGCCCAAGCAGACCCGCCTGCTCCGGCAGGAGCGCCTGGTGGTCCCGCACCACCCCGTCCGCGCCGGTTCCTGA	MLVVGASAAGLATVEALRRKGYTGEVTLLGDEGHPPYDRPPLSKQVLSGRWEPDRAHLRTAEALEALRARLVLGDAAVSLDVGARAVRTASGATLTADTVVVATGARPRTLGGGPRVAGVHVLRTVADALVLRADLVAARRLVVVGDGVLGTEIAATARELGVDVTVLGLQPSLMAFPLGPLASGALTALHVERGVRLRPGTAFDGLVDDGDRVTGVRVAGGEVLPADVVVVAVGAVPNTEWLADSGLALDNGVVCDERCRAAEGVYAVGDVARWQHPRLGSLRLENRTNATEQAAAVAEDILGADRPYAPVPYFWTDQFDAKIHVHGVPTAGTRVTVVEGEVADRRFVALYEQDDGEAVGVLGWNMPKQTRLLRQERLVVPHHPVRAGS	MSPQQEPTAQPPRRHRVVIIGSGFGGLNAAKKLKRADVDIKLIARTTHHLFQPLLYQVATGIISEGEIAPPTRVVLRKQRNVQVLLGNVTHIDLAGQCVVSELLGHTYQTPYDSLIVAAGAGQSYFGNDHFAEFAPGMKSIDDALELRGRILSAFEQAERSSDPERRAKLLTFTVVGAGPTGVEMAGQIAELAEHTLKGAFRHIDSTKARVILLDAAPAVLPPMGAKLGQRAAARLQKLGVEIQLGAMVTDVDRNGITVKDSDGTVRRIESACKVWSAGVSASRLGRDLAEQSRVELDRAGRVQVLPDLSIPGYPNVFVVGDMAAVEGVPGVAQGAIQGAKYVASTIKAELAGANPAEREPFQYFDKGSMATVSRFSAVAKIGPVEFSGFIAWLIWLVLHLAYLIGFKTKITTLLSWTVTFLSTRRGQLTITDQQAFARTRLEQLAELAAEAQGSAASAKVAS	84.23	gnl|BL_ORD_ID|1990|hsp_num:0	1203			48	576	isoniazid
BGC0001193.1|Thiolutin_7 # 11901 # 12107 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GAGGG;rbs_spacer=9bp;gc_cont=0.700	BGC0001193.1|Thiolutin_7 	11901	12107	-	Loose	1900	21.9422	MuxC	32.26	3004075	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAGATCACTGTGGACGAGGACAAGTGCTGCGGCGCGGGCATGTGCGCACTGGCGGCGCCGGAGGTGTTCGACCAGCGCATCGGTGACGGCGTGGTGGTCGTGCTGGACGCGGAGCCTGCCGAGCACCTGCACGAGAGCGTCCGCGAGGCCGTGGAGGTCTGCCCGGTCGCGGCCATCACGCTGACGCTCGGGGCCGACGCGTGA	MKITVDEDKCCGAGMCALAAPEVFDQRIGDGVVVVLDAEPAEHLHESVREAVEVCPVAAITLTLGADA	MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL	6.56	gnl|BL_ORD_ID|2367|hsp_num:0	2720			1869	1962	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0001193.1|Thiolutin_8 # 12859 # 13524 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.740	BGC0001193.1|Thiolutin_8 	12859	13524	-	Loose	1050	28.1054	lmrC	35.19	3002881	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGAGCGATGACGGTTCCCGGCCCGAGTTGTTCGAGCTGTTGGCGCGCGTCGGCAAGGCACTGGGCAACGGCAAGCGGTTGGAGCTGATCGAGCTGCTGGTGCAGCGCTCCAGGGGCGTCGTGGAGCTGGCGCGCGCGGCCGGGCTCAACGTGACGACGACGTCGGCGCACCTGCAGACGCTGCGGCAGGCGGGTCTGCTCACCACCTCGCGCGACGGCACCACCATCCGCTACAGCATCGCCAGCGCCGAGGTCGCCGCGCTGTACGCCCGGCTGCTGACGGTGGCCGCCACCCAGTCCGCGGAGGTCGCCGTGGCCCGGCGCAGGCACGTGGGCCCGGACGACACCGAGGAGGTCGACCGCGACGAGCTGCTGCGCCGGGTCAGCGCGGGGCGGGCCGTCGTGGTGGACGTGCGGCCGAAGACCGAGTACGACGCGGGGCACATCCCCGGCGCGCTGTCCATCCCCATGGAGGAGCTGGCCGGGCGCCTCGACGAGCTGCCCACCGACCTGGACATCGTCGCGTACTGCCGGGGCGCGTTCTGCTCCTACGCCCACGACGCCGTCCGCCTGCTGTCCACGCGCGGCTACCGCGCGGTGCGGCTGGCGGACGGCGTCCTGGAGTGGCAGGTGGCGGGCCGGCCGCTCACCGGCGGCGCGACCTGA	MSDDGSRPELFELLARVGKALGNGKRLELIELLVQRSRGVVELARAAGLNVTTTSAHLQTLRQAGLLTTSRDGTTIRYSIASAEVAALYARLLTVAATQSAEVAVARRRHVGPDDTEEVDRDELLRRVSAGRAVVVDVRPKTEYDAGHIPGALSIPMEELAGRLDELPTDLDIVAYCRGAFCSYAHDAVRLLSTRGYRAVRLADGVLEWQVAGRPLTGGAT	MADASIVCTNLSFSWPDETPVFDGLSFALGAGRCGLVGPNGAGKSTLLRLAVGELTPTAGSITAQGHVGYLPQSLPLIDGTVDEALEIASIRAALHAIESGDVDEAHFTTVGDHWDIEERTTIVLDRLGLGDVSLDRPLRSLSGGQVLAIGLAAQLLKRPDVLILDEPTNNLDLAARQRLYQVVEEWKGALLVVSHDRELLDRVDTIAELQASELRLYGGNFTAYTEAVELEQENVQRAVRGAEQELRRHKREAQAAQERAQRRASNAKRNKASSGVPRIHAGALQRQAQESAGRAASVHQDRVSQAKAKLDEASQGMREEARLAITLPQTSVPAGRTVLTCHEANVRYGERTLFTGSGVDLGIRGPERIALLGPNGSGKSTLLKLIAGELEPSSGTVTAPTDRVSYLSQRLDLLDLDASVLDNLRRFAPHLQDGEVRYRLAQFLFRGDRVHRTAGWLSGGERLRATLACVLSTDPAPQLLLLDEPTNNLDLNSAAQLENALNAFQGAFVVVSHDQAFLRAIGVSRWLRLADGTLEEIAEADDAWPHRDK	40.18	gnl|BL_ORD_ID|900|hsp_num:0	974			1446	1608	lincomycin; clindamycin; celesticetin
BGC0001193.1|Thiolutin_9 # 13965 # 14282 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.604	BGC0001193.1|Thiolutin_9 	13965	14282	+	Loose	950	26.5646	msrE	36.36	3003109	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic target protection	msr-type ABC-F protein	GTGTTCCAGTCGATCCGAATAGCCGGAAGAAGTGTCCGGCGGTGGTGCGGCCAAGCGGCCGACCAGTGGTTCCTGCAGGTAGCTCCGTCACCGAGCGACCTTGCTTTCCGTTGCATTTTGGCTACGCTGGTCCGGGGACCTGTTCGATACGCGCGGTGGCTGGGTGGCACCGCGTCGTTGTCCGGGTCCGCAACTATGGGGAAGACTTTCCGGCTGCGTGTGCTGACTGTGTCGGCTAGGGGGAGAAAAATTGCTCCGCTATGTCGAGTACCAATTACCGGATGTGATCGACCGATGTGTTCCGGAGTCCGCGGATAA	MFQSIRIAGRSVRRWCGQAADQWFLQVAPSPSDLAFRCILATLVRGPVRYARWLGGTASLSGSATMGKTFRLRVLTVSARGRKIAPLCRVPITGCDRPMCSGVRG	MSLIIKARNIRLDYAGRDVLDIDELEIHSYDRIGLVGDNGAGKSSLLKVLNGEIVLAEATLQRFGDFAHISQLGGIEIETVEDRAMLSRLGVSNVQNDTMSGGEETRAKIAAAFSQQVHGILADEPTSHLDLNGIDLLIGQLKAFDGALLVISHDRYFLDMVVDKIWELKDGKITEYWGGYSDYLRQKEEERQHQAVEYELMMKERERLESAVQEKRQQANRLDNKKKGEKSKNSTESAGRLGHAKMTGTKQRKLYQAAKSMEKRLAALEDIQAPEHLRSIRFRQSSALELHNKFPITADGLSLKFGSRTIFDDANFIIPLGAKVAITGSNGTGKTSLLKMISERADGLTISPKAEIGYFTQTGYKFNTHKSVLSFMQEECEYTVAEIRAVLASMGIGANDIQKNLSDLSGGEIIKLLLSKMLLGKYNILLMDEPGNYLDLKSIAALETMMKSYAGTIIFVSHDKQLVDNIADIIYEIKDHKIIKTFERDC	21.38	gnl|BL_ORD_ID|27|hsp_num:0	33			960	1059	erythromycin
BGC0001193.1|Thiolutin_10 # 14248 # 15279 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=15bp;gc_cont=0.752	BGC0001193.1|Thiolutin_10 	14248	15279	+	Loose	1900	25.409	MexI	33.33	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGATCGACCGATGTGTTCCGGAGTCCGCGGATAATATTGAGCTGTGGCTCGACGGTCAATCCGCGGTGCCGGTCCCGGTCACCGCGCTGAGGCCGTCGGACTCCCCCCGGCTCGCTGGGGAGGACTGCGAGCACGCCCGTGCCCTGGCCGAGTCGGAGACGGCTCTGCCGCCGGTGCTGGTGCACCGGCCCACCATGCGGGTCATCGACGGGATGCACCGGCTCCACGCCGCGGTGCTGCGCGGTGAGGAGACGATCCGCGTGCGCTTCTTCGACGGTGACGCCGCCGACGCCTTCGTGCTCGGCGTGCGCTCGAACGTCAAGCACGGCAGACCGCTGACGCTGGCCGACCGGCGGGCCGCGGCCCTGCGCATCATCGCGTCGCACCCGCAGTGGTCCGACCGGGCCATCGCCTCGGCCACCGGGCTCGCGGCCAAGACCGTCGGCGCGATCCGCGCCTGCGCAACTGGTGAGGATCCGCAGTCGCGCAGCCGGGTCGGCCGGGACGGCCGCGTCCGGCCGCTCAACAGCGCGGACGGCCGGCTGCGGGCCAGCGCCCTGCTGCGGGAGAAGCCCTCCGCCTCGCTGCGGCAGATCGCGGTGCAGGCGGGCGTCTCGCTGGGCACGGTGCGCGACGTGCGCGACCGCCTGGCCCGCGGCGACGACCCGGTGCCGCCCCGGCAGCGCCGCGGTCCGCGCGGCACGGGCTCGGCTTCGGGCGCCGGCTCCTCCACTCGGGCCAAGGAGCCGCAGCGGGCGCCCGCGGCCGACCGGTGCGCCGAGCGGGTGGAAGCGCAGCGGTCGCTGCTGGTGCGGCTCAAGCGCGACCCGTCGCTGCGGTTCACCGAGGCGGGCCGCACGCTGATCCGCCTGCTCAACTCGCACGTGGTGGACCAGCCGGAGTGCCGGCAGGTCCTCGACGCGGTCCCGGCGCACTGCCGCGGCATCGTCGCCGAGATCGCCCAGTCCTACGCGGACACCTGGAAGGAGTTGGCCGTGTGGCTGGACCGGGGGACGTCCGCCGGGTCCTGA	MIDRCVPESADNIELWLDGQSAVPVPVTALRPSDSPRLAGEDCEHARALAESETALPPVLVHRPTMRVIDGMHRLHAAVLRGEETIRVRFFDGDAADAFVLGVRSNVKHGRPLTLADRRAAALRIIASHPQWSDRAIASATGLAAKTVGAIRACATGEDPQSRSRVGRDGRVRPLNSADGRLRASALLREKPSASLRQIAVQAGVSLGTVRDVRDRLARGDDPVPPRQRRGPRGTGSASGAGSSTRAKEPQRAPAADRCAERVEAQRSLLVRLKRDPSLRFTEAGRTLIRLLNSHVVDQPECRQVLDAVPAHCRGIVAEIAQSYADTWKELAVWLDRGTSAGS	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	33.33	gnl|BL_ORD_ID|4683|hsp_num:0	1647			2115	2289	acriflavine; tetracycline; norfloxacin
BGC0001193.1|Thiolutin_11 # 15332 # 15913 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.723	BGC0001193.1|Thiolutin_11 	15332	15913	-	Loose	300	26.5646	dfrA27	45.71	3004550	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGATCGAGAACAGCGGAATTCCCACCGGCCCGCGCGTGCTCGTGGGAGCCACCGGTTCGGTCGCCGTGACGGCCCTGCCCGCCTACCTCACCGAGATGCGCAGCAGGCTCGGCGGCACCTACACCGTGCTGATGACGCACACGGCGACGACCTTCCTGCCACCGACCACCGTGGCGATCCACGCCGAGCGCGTCGTCAGCGGCGAGTCCCCCGAGGACTGGCCGACCGACAAGCCGTCCCGGCTGGCCGCCGGCCACGACGTCGTGGTGGTGCTGCCCGCGACGGCGAACATGCTGGCCGCCGTCGCGACCGGCGCGGCGCCCAACCGGCTGACGACGGTGATCCTGTCCACCACCTGCCCGGTGGTGTACTTCCCGTCGATGGGGGCGGCCATGTGGCGCAAGCCCGCGGTGCAGCGCAACGTCGCGCAGATCCGCGCGGACGGCGGCCACGTGCCCGAGCCGGAGTGGCACGACAGCTACGACGTCGGGTCGCGCTCCATGTCGCACCACCCGACGATGCCCCCGCCGCCGGAGGTGGCGAAGATCGTCGGCGACCTGCTGGCCGCGCAGTCGGCGTGA	MIENSGIPTGPRVLVGATGSVAVTALPAYLTEMRSRLGGTYTVLMTHTATTFLPPTTVAIHAERVVSGESPEDWPTDKPSRLAAGHDVVVVLPATANMLAAVATGAAPNRLTTVILSTTCPVVYFPSMGAAMWRKPAVQRNVAQIRADGGHVPEPEWHDSYDVGSRSMSHHPTMPPPPEVAKIVGDLLAAQSA	MKISLMAAKARNGVIGCGSDIPWNAKGEQLLFKAITYNQWLLVGRKTFEAMGALPNRKYAVVSRSGSVATNDDVVVFPSIEAAMRELKTLTNHVVVSGGGEIYKSLIAHADTLHISTIDSEPEGNVFFPEIPKEFNVVFEQEFHSNINYRYQIWQRG	122.93	gnl|BL_ORD_ID|2705|hsp_num:0	3258			147	252	trimethoprim
BGC0001193.1|Thiolutin_12 # 16130 # 19384 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=AGAGG;rbs_spacer=7bp;gc_cont=0.738	BGC0001193.1|Thiolutin_12 	16130	19384	+	Loose	1000	144.436	almE	31.86	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGAACGACCAATATTCATCTCTGATGGAGCTCCTGAATGGTCGGGCAGAATCAAAGTGTTCCCCGGAAGCACCTGTCCCGAACCACCGGCCGTTCCCGCTGACCGATCTCCAGCACGCCATGGTGATCGGCCGCCACCGGGGGATCGAGCTGGGCGGGGTGGCCGGTCACGTCTACTTCGAGTTCGAGGGGCCGGCCCTGGACGTCGAGCGGCTGTCCCGGGCGCTGCGCGAGGTCGTCGCCCGCCACGACATGCTGCGCGCGGTGACCGCGCCCGACGGCGCCGGCCAGTGCGTGCTGGACGAGGTGCCCGACTACGAGATCCGGGTCACCGACCTGCGCGACCGCACCGACGAGGAGCGCCGCGCCGCGCTGGACGCGATCCGGGCCGAGCTGTCCGACGAGGTCCGGCCCACCGACCAGTGGCCGCTGTTCGACATCCGCGCCACGCTGCCCGCCGAGGGCCGCACCCGCCTGCACCTGAGCTTCGACCTGCTGTTCGTCGACGTGCGCAGCCTGTACGCCGTGCTGGCGGAGTGGCGCCGCCGCTACGACGAGCCGGACTGGCGGCCCGAGCCGCTGGACGTGACCTTCCGCGACCACGTCCTGCGCCAGGCGGAACTGCTCGACGGCGACGAGGGGCGCCGGGCCCGGGAGTACTGGGAGGCCCGCCTGGACGAGCTGCCCGCCGGGCCGGACCTGCCGCTGGCCACGTCGCCGGAGCTGGTCGGCCGGCCGGTGTTCCGCAAGCTCGACGCCGTGGTGCCCGCGCCGCGCTGGGCGGCGATCAAGGAGGCCGCCGCCCGCCGTGGCGTGCCGGTGAACGTCGTGCTGCTGGCCGCTTACGGCGAGGTGCTGCGCCGGTGGTCGCGGCGGTCGGACTTCACGATCGCGCTCACCCTGCTCGACCGGCTGCCGGTGCACCCGCGCATCGGCGAGGTGGTGGGCGACTTCCTGTCCCTGGGCCTGCCGGTGACCCGCGCGTCGGGCGGTGGGACGTTCGAGGACCGCGTCCGCGCGCTGGCCGACCAGGTGAGCGCCGACGCCGACCACGCGGCCTTCAGCGGCATCCGCGTGCTGCGGGAGCTGACCCGCGCCCGGGGCGACGGCCGCCCGGTGGGGATGCCCGTGGTCTACTCCAGCACGCTGGGCGGCGAGCCCGGCGGCGACGCCCTCGGGCTGTTCGGCGAGGTCGTGCACAGCGCCTCCCAGACCCCGCAGATCTGGCTGGAGAACCAGGTCCGCGAGCAGGCCGGCGGCCTGGCGCTGAGCTGGAACGCCGTCGAGGGGCTGTTCCCCGCCGGCGTCGTCGACGACATGTTCGACGCCTACCTGCGGCTGCTGGCCGCGATCGCCGACGACGAGGCGCTGTGGGCCCGCACCGGCGGCGTCGTGCCGCTGCCCGAGCACCAGCGCCGGGAGCGGGACGAGGCCAACGACACCGCCCAGGACCTGCCGCCCGCGCTGCTGCACGAGCTGGTGGGCGCCGCGGCGGCGCGGACGCCCGACGCCGTGGCGGTGATCGCCGACGGCGCCGAGGTGACCTTCCGGCGGCTGAGCGAGGACGCGCACCGGCTCGGGCACCGGCTGCGCGCCGAGGGCCACGGCGTGCCGAACACGCTCGTCGCGGTGTCGATGCGGCCGGGCGCGCGGCTGTTCTCCGCGCTGCTGGGCGTGCTGCACTCCGGCGCCGCCTACGTGTCGATCGACCCGGAGCTGCCCGAGCAGCGCCGCCTGAAGCTGCTGGCGCGCTGCGCCGCCACGGCCGTCGTCACCGAGCCCGAGCTGCGCGACCACCTGACGTGGCCCGAGGACGTCCAGGTGATCACGCCGGACGACGAGGCCACCCTCGCCTGCCCGGCGCAGCGGCCCGAGGACGTCCAGGGCCACGACGACCTGGCGTACGTGATCTTCACCTCCGGGTCGACCGGCGAGCCCAAGGGCGTGATGATCACCCACCGCTCGGCCGGCAACACCGTCCAGGACATCAACCGCCGGTTCGGCGTCGGCCCGGGCGACCGGGTCCTCGCGCTCGCGCCCACCGGCTTCGACCTGTCGGTCTACGACGTGTTCGGCGTGCTGGGCGCGGGCGGCGCGATCGTCGTGCCGGAGGCCGGGCGCAGCGGCGACGTCGCGCACTGGACCGAGCTGATCGACCGGCACCGGGTGACGGTCTGGAACAGCGTTCCCGCGCCGATGCGGCTGTGGGCGGACTCGCTGGCCGACGCGCCCGCCGAGGCCGGCGCGAGCGTGCGGCTGGCGCTGCTCAGCGGCGACTGGATCCCGGTGACGCTGCCGGGCAGGCTGCGCGAGCGCTTCCCGGACATGGCCGTGATCAGCCTCGGCGGCGCCACCGAGGGGTCGATCTGGTCGATCCACTACCCGATCGGCGAGGTGTCGCCGGACTGGGCGAGCATCCCGTACGGCAAGCCGCTGGCCAACCAGACCATGCACGTCCTCGACGAGCGGCTGGAGCCGTGCCCGGTCTGGACGACCGGCGAGATCCACATCGGCGGCGTCGGCGTCGCGGCGGGCTACTGGGGCGACCCGGAGCGCACCGCGGAGCGGTTCTTCACCCACCCGGTCACCGGCGAGCGGCTCTACCGGACCGGGGACCTGGGCCGCTACCTGCCCGGCGGCGACATCGAGATCCTGGGCCGGACCGACTTCCAGGTCAAGATCAACGGCTACCGGGTCGAGCTGGGCGAGATCGAGTCGGCGCTGAGCAAGCAGCCCGGCGTCGGCCACGCGCTGGTCGCCGCGCCGGTGCACCCGCTGAGCGGGCAGCGGCAGCTCGCCGCGTACGTCATCGCCGACGGCAGCGGCAAGCCCGACCCGTCGCTGCTGCGCAAGGCGCTGGCGGACGTGCTGCCCGGCTACATGGTGCCCACGCACTACGTCGCGGTCGACGCGTTCCCGATGACGCCCAACGGCAAGATCGACCACGCCGCGCTGCCGACGCCGTGGCACGACGGCGGCGAGAGCGACGAGCGGGCCGAACCGCGCGACGACGTCGAACAGCGCCTGCTGACGATCTGGTTCGACCAGCTGGGCCACACCGACTTCGGCGTGGAGGACGGCTTCTTCGACGTCGGCGGCGACTCGCTGCACGCGGTCGGCATCATCGGCAAGCTGCGCGCGGAGTTCGAGATCGACTCGGCGGCCGAGCAGAAGGTCGTCGAGGGCCTGTTCACCAACTCCAGCATCACCGAGTTCGCGGAGCTGATGCGCTCACTGGTGAAGGTGCGCGCATGA	MNDQYSSLMELLNGRAESKCSPEAPVPNHRPFPLTDLQHAMVIGRHRGIELGGVAGHVYFEFEGPALDVERLSRALREVVARHDMLRAVTAPDGAGQCVLDEVPDYEIRVTDLRDRTDEERRAALDAIRAELSDEVRPTDQWPLFDIRATLPAEGRTRLHLSFDLLFVDVRSLYAVLAEWRRRYDEPDWRPEPLDVTFRDHVLRQAELLDGDEGRRAREYWEARLDELPAGPDLPLATSPELVGRPVFRKLDAVVPAPRWAAIKEAAARRGVPVNVVLLAAYGEVLRRWSRRSDFTIALTLLDRLPVHPRIGEVVGDFLSLGLPVTRASGGGTFEDRVRALADQVSADADHAAFSGIRVLRELTRARGDGRPVGMPVVYSSTLGGEPGGDALGLFGEVVHSASQTPQIWLENQVREQAGGLALSWNAVEGLFPAGVVDDMFDAYLRLLAAIADDEALWARTGGVVPLPEHQRRERDEANDTAQDLPPALLHELVGAAAARTPDAVAVIADGAEVTFRRLSEDAHRLGHRLRAEGHGVPNTLVAVSMRPGARLFSALLGVLHSGAAYVSIDPELPEQRRLKLLARCAATAVVTEPELRDHLTWPEDVQVITPDDEATLACPAQRPEDVQGHDDLAYVIFTSGSTGEPKGVMITHRSAGNTVQDINRRFGVGPGDRVLALAPTGFDLSVYDVFGVLGAGGAIVVPEAGRSGDVAHWTELIDRHRVTVWNSVPAPMRLWADSLADAPAEAGASVRLALLSGDWIPVTLPGRLRERFPDMAVISLGGATEGSIWSIHYPIGEVSPDWASIPYGKPLANQTMHVLDERLEPCPVWTTGEIHIGGVGVAAGYWGDPERTAERFFTHPVTGERLYRTGDLGRYLPGGDIEILGRTDFQVKINGYRVELGEIESALSKQPGVGHALVAAPVHPLSGQRQLAAYVIADGSGKPDPSLLRKALADVLPGYMVPTHYVAVDAFPMTPNGKIDHAALPTPWHDGGESDERAEPRDDVEQRLLTIWFDQLGHTDFGVEDGFFDVGGDSLHAVGIIGKLRAEFEIDSAAEQKVVEGLFTNSSITEFAELMRSLVKVRA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	194.96	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1629	colistin A; colistin B
BGC0001193.1|Thiolutin_13 # 19381 # 20931 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.749	BGC0001193.1|Thiolutin_13 	19381	20931	+	Loose	1800	28.8758	MexD	28.95	3000801	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCGACGAGCGGTGGGACCTGGTGGTCGTGGGCGGCGGGTCGGCCGGCGTGGTGGTGGCCACCCGCGCCGCCGCCCGCGGCAGGCGCGTGCTGCTGCTGGAGGCGGGGCCGGACCAGCCGGTGTCCCGGGACGAGCCCAACCCCGTGCGCGACGGCACCCGGCTGATCCTCGACGGGTTCAACTGGGACCACCGGGCCAACCTGCGCACCGCGGGCGGCCGGCCGTCCCGGGCGCTGTGGAGCCGGTTCCCCTACCCGGTGGGCAAGGTCGTCGGCGGCGGCTCCTCGGTCAACGGCGCGGTGGCCATGCGCGCCCTGCCCCGGGACTTCGACGACTGGGTCAAGCACGGCAACCCGGACTGGTCCTGGGACCACGTGCTGCCCCACTTCCGGGCGATCGAGCGCGACGCCGACTTCCCGGGCGGCGACCACGGCGACAGCGGGCCCATCCCGATCCGGCGTCCCCGCCGGGAGGGCCTGCACGTGCTGGACGCCGCGTTCTGGGTCGAGTGCGAGCGGATGGGCGTGCCGTCCCTGGCCGACCTCAACGGCACCGACGAGTTCGGCGTCGGCGCGGTGCCCGCCAACGCGGTCGACGGCGAGCGGATGGACGTCACCGCCACCTACCTGGCGGCGGCGCGCCACCTGCCGAACCTGGAGGTCCGGCCGCGCAGCCGGGTCCTGCGGGTGCTGCTCGACGGGCGGCGCGCGGTCGGCGTCGAGGTCGAGCGGGACGGCGCGGTCTCGGTCGTGCGCAGCGACGACGTCGTGCTCAGCGCCGGCGCGATCGGCTCGCCGCTGGTCCTGCAGCGCTCGGGCATCGGCCCGGCCGGCGTGCTCGACGCGCTGGGCGTGCCGAGGGTCGCGGAGCTGGCCGGGGTCGGCGAGAACCTGGTCGACCACCCGTCGGTGGTGCTGTGGGCCAAGCCGCGCGACGGCCTGTGCCGGCCCGGCGTCCCGTGGCGGCAGGTCGCCGCGCGGGTGCCCAGCGGCCTGGACGACGACGTGGACCTCCAGGTGTGGCTGCTCAACAACGTCGAGCGGACCACCATCCCGGGGTTCGCCGACCGGCTCGGCTGGCACATGGTCGTCGGCATCTCGGTGATGCTGCTGCGCCCGGAGGGTCACGGCCGGGTGCACGCCGACCCGTCCGGCGCGCCGGTGATCGAGCTGGGCTTCGGCTCGGTCGACGAGGACGTGGAGCGCCTGGCGCTGGGCGTGCGCAAGGCGTGGCGCATCCTGCGGTCGCCGGTGTTCGCCGACAACATCGAGGAGGTCCAGCTGTGGACCGACTCGATGGTGGAGGACGACCAGCTGCTGCGCAAAGCCGTGCGCAACGTGATGAGCCCGGGGTGGCACGCCATCGGCACCAACCGGATGGGCCCGCCGGACGACCCGATGTCGGTGGTGGACCAGCGCTGCCGGGTGCACGGGTTCACCGGGCTGCGGGTGGTGGACGCCTCGGTGTTCCCCACCATGCCCGGTGCGCCGACCAACCTGACGACGATCATGCTCGCCGAGCGGATCGCGTCCGAGGCGGGGGAGTGA	MTDERWDLVVVGGGSAGVVVATRAAARGRRVLLLEAGPDQPVSRDEPNPVRDGTRLILDGFNWDHRANLRTAGGRPSRALWSRFPYPVGKVVGGGSSVNGAVAMRALPRDFDDWVKHGNPDWSWDHVLPHFRAIERDADFPGGDHGDSGPIPIRRPRREGLHVLDAAFWVECERMGVPSLADLNGTDEFGVGAVPANAVDGERMDVTATYLAAARHLPNLEVRPRSRVLRVLLDGRRAVGVEVERDGAVSVVRSDDVVLSAGAIGSPLVLQRSGIGPAGVLDALGVPRVAELAGVGENLVDHPSVVLWAKPRDGLCRPGVPWRQVAARVPSGLDDDVDLQVWLLNNVERTTIPGFADRLGWHMVVGISVMLLRPEGHGRVHADPSGAPVIELGFGSVDEDVERLALGVRKAWRILRSPVFADNIEEVQLWTDSMVEDDQLLRKAVRNVMSPGWHAIGTNRMGPPDDPMSVVDQRCRVHGFTGLRVVDASVFPTMPGAPTNLTTIMLAERIASEAGE	MSEFFIKRPNFAWVVALFISLGGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDSVTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQAVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFFSSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKGTLDDPQEFGQVVLRANEDGSLVPARRCRAPGTRQGELQHFLATERHAHRGRGYPAVARGQRDPDPTLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLFLENVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSILFSGFLALTFTPALCATLFKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGRFMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKSREAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSSAAEIAALNEHFALPDDGTVMAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEAPQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPESVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEMERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLIVPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAIEAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPICFVWLLSLLRSKPAPIEQAASAGE	49.47	gnl|BL_ORD_ID|1485|hsp_num:0	1523			441	669	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
BGC0001193.1|Thiolutin_14 # 20928 # 21683 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GAGG;rbs_spacer=7bp;gc_cont=0.761	BGC0001193.1|Thiolutin_14 	20928	21683	+	Loose	500	31.187	AIM-1	38.64	3000853	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	AIM beta-lactamase	GTGACCGGCGTGGCCGCACGGCTCTACTGCTTCCCGCACGCGGGCGCCACCGCCGCGGTCTACCGGCCGTGGAAGGAGGCGGCCGGTCCCGACCTGCGGGTCGTCGGGCTCGACCGCCCCGGCCGGGGCTCCGCGGCGCGGCACCCGAAGATCGGCGACCTGCCGTCGCTGGTGGACTGGACGGCCGCGCGGCTGCTCGCCGACCTGGGCGAGGGCCGCGCCGAGGACCCGGGGCTGCGCTGGGCGACCTTCGGGCACAGCTTCGGCGCCCTGCTCAGCCTGGCCGTCGCCGCGCGGGTGGCGGCGGCGCTGGACGAGCCGCCGGCGTGCGCGGTGCTCTCCGCCGCGCTGCCGCCCCGGACGCAGGAGGTGGGCGACGTGACGACCTCGCTGTCCGACGAGGAGTTGCTCGCCAAGATCATGCGCGACGGCGGCACCCCGCCCGAGGCGGTGTCCTCCAGCGCCATGGCGGGCTACTTCCTGTCGCTGATGCGGGAGGACTACGGCATCCGCGCGCAGTACCCGAGCCAGACCGGCCTGCGGGTGGACTTCCCGCTGGCGCTGGTCGCGGCGGCCGACGACGTCCACGTGCCGCCCGAGCGGATGTGGGAGTGGGCGGAGCACAGCAGCGAGCCGTGCCGGCGGCTGGAGCTGGCGGGGGACCACTTCGCCGCGATCCGCGACCCCCGCGAGGTGCTGGCGCTGGTGCACGAGAACACGACCCGAGCCGCTGATCTGGCCGACAAGGGGAGATGA	MTGVAARLYCFPHAGATAAVYRPWKEAAGPDLRVVGLDRPGRGSAARHPKIGDLPSLVDWTAARLLADLGEGRAEDPGLRWATFGHSFGALLSLAVAARVAAALDEPPACAVLSAALPPRTQEVGDVTTSLSDEELLAKIMRDGGTPPEAVSSSAMAGYFLSLMREDYGIRAQYPSQTGLRVDFPLALVAAADDVHVPPERMWEWAEHSSEPCRRLELAGDHFAAIRDPREVLALVHENTTRAADLADKGR	MKRRFTLLGSVVALALSSTALASDAPASRGCADDAGWNDPAMPLKVYGNTWYVGTCGISALLVTSDAGHILVDAATPQAGPQILANIRALGFRPEDVRAIVFSHEHFDHAGSLAELQKATGAPVYARAPAIDTLKRGLPDRTDPQFEVAEPVAPVANIVTLADDGVVSVGPLALTAVASPGHTPGGTSWTWRSCEGDDCRQMVYADSLTAISDDVFRYSDDAAHPGYLAAFRNTLARVAALDCDILVTPHPSASGLWNRIGPRAAAPLMDTTACRRYAQGARQRLEKRLAEEAATSPSSGARP	82.84	gnl|BL_ORD_ID|652|hsp_num:0	707			510	639	
BGC0001193.1|Thiolutin_15 # 21685 # 22827 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=AGGG;rbs_spacer=8bp;gc_cont=0.710	BGC0001193.1|Thiolutin_15 	21685	22827	+	Loose	500	25.409	chrB	50.0	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	GTGGAGCACAACCCCTACGACGAGGTGCACGAGGACTTCCGGTCCCTGTGCCGCGCCTTCCTGGAGCGGGAGGCGGTCCCGCACCACGACCAGTGGGAACGGGACGGCATCATCGACAGCGCCCTGTGGAAGAAGGCCGGCGCCGCCGGGCTGCTCGGCGTGGACGCCCCCGCCGAGCACGGCGGCGGCGGCCAGGACGACTTCCGGTTCACCGCGGTGTTCATCGAGGAGCTGACCAGGGCCGGGGTGACCGCACCGGGCCTGGTGGCGCACAACGACATCGTCTCGTCCTACTTCGCCGCCCGCACCACCCCGGAGCAGCAGGCCCGGTGGCTGCCCGGCCTGTGCTCGGGCGAGCAGATCGCCGCCATCGCGCTGAGCGAACCCGAGGCCGGCTCGGACCTGGCGGGCATCCGGACCACCGCGGTGCGCGACGGCGACCACTACGTCCTCAACGGGCAGAAGACGTTCATCACCAACGGGGAGAAGGCGGGGCTGGTGCTCGTGGCGGTCAAGACCGCCACGCCGCGCGGCGCGCCCGGGATCAGCCTGCTGGTCGTGGAGGCCGGCACGCCCGGCTTCTCCCGGGGCCGGCGGCTGGACAAGCTCGGCTGGCGGGCCAGCGACACCAGCGAGCTGTTCTTCGACGACTGCCGGGTGCCGGTGGCGAACCTGCTCGGCCGGGAGAACGCCGGGATGGGCTACCTCATGGCCGGGCTGCCCAGGGAGCGGCTGTGCATCTCGGCGGTCGCGGTCGCCACGGCGGAGAAGATGCTCGCCGACACCCTGGAGCACGCCCGCAACCGCCAGGCGTTCGGCCAGGCCATCGGCAGCTTCCAGCACAACAAGTTCGTGCTGGCCTCGCTCGACACCGAGATCACCGTGGCGCGGGTGTTCTTCAACCACTGCATGGCGGAGCTGAACGCCGGGCGGCTGACCGTCACCGACGCGGCCAAGCTCAAGTGGTGGACCACCGAGCTGCAGGTCCGCGTCGCCGACAGCTGCCTGCAGCTGCACGGCGGCTACGGTTACCTCCGGGAGAGCTCCATCGCCCGCGAGTGGGCCAACAGCCGCGTGCAGACCATCTACGGCGGCACCACCGAAATCATGAAAGAGCTGATCGGCCGGTCTCTCGGCCTGTGA	MEHNPYDEVHEDFRSLCRAFLEREAVPHHDQWERDGIIDSALWKKAGAAGLLGVDAPAEHGGGGQDDFRFTAVFIEELTRAGVTAPGLVAHNDIVSSYFAARTTPEQQARWLPGLCSGEQIAAIALSEPEAGSDLAGIRTTAVRDGDHYVLNGQKTFITNGEKAGLVLVAVKTATPRGAPGISLLVVEAGTPGFSRGRRLDKLGWRASDTSELFFDDCRVPVANLLGRENAGMGYLMAGLPRERLCISAVAVATAEKMLADTLEHARNRQAFGQAIGSFQHNKFVLASLDTEITVARVFFNHCMAELNAGRLTVTDAAKLKWWTTELQVRVADSCLQLHGGYGYLRESSIAREWANSRVQTIYGGTTEIMKELIGRSLGL	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	135.71	gnl|BL_ORD_ID|274|hsp_num:0	305			579	681	tylosin; chalcomycin; mycinamicin
BGC0001193.1|Thiolutin_16 # 22824 # 23315 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.691	BGC0001193.1|Thiolutin_16 	22824	23315	+	Loose	150	25.7942	nimH	30.77	3007110	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic inactivation	nitroimidazole reductase	GTGACGCTGGGCGAGGAAGGAAGTGCTGTGGGAGAACAGGTTCCGTCCGTGTACGAGTGGGCCGGTGGCGCCGAGGCGTTCGAGCGGCTCACGGAGGTCTTCTACCGCAAGGTGCTCAAGGACGACCTGCTGGAGCCGCTGTTCCGCCGCATGACGCCGGAGCACCCGCACGACGTGGCCGTCATGCTGAGCGAGGTGTTCGGCGGCCCCCGGAAGTACACCGACGAGCACGGCGGCTTCAAGCGGCTGGTCGGCAAGCACCGCAACCGCGACATCCAGCCGGAGCAGCGCAACCGGTGGGTGCAGCTGATCCTGGAGTCGGCCGACGAGGTCGGGTTCCCCGAGGACGCGGAGTTCCGGTCGGCGTTCGTGAGCTACATCGAGTTCGGCTCGCGCCGCGCGATGGCCAACTCGAAGCCGGGCGCGGTGCCCAAGGAGCGGGAGATGCTCAAGCGCTGGGGCTGGGGCGAGGCGACTCCCGGCGAGGAGTGA	MTLGEEGSAVGEQVPSVYEWAGGAEAFERLTEVFYRKVLKDDLLEPLFRRMTPEHPHDVAVMLSEVFGGPRKYTDEHGGFKRLVGKHRNRDIQPEQRNRWVQLILESADEVGFPEDAEFRSAFVSYIEFGSRRAMANSKPGAVPKEREMLKRWGWGEATPGEE	FREMRRKRQLLPTEESITILEKMTNGTLALHGDNGYPYAVPVSYVYADGKIYFHSAVKGHKVDAILRNNKVSFCVVEQDDVKPAEFTTYFRSVIAFGKARILADEGEKQLAFRLLADKYSHGEVGMEAEIAKGFNHLLMVEIMVEHMTGKE	107.95	gnl|BL_ORD_ID|4787|hsp_num:0	5783			135	312	metronidazole
BGC0001193.1|Thiolutin_17 # 23643 # 25094 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=7bp;gc_cont=0.720	BGC0001193.1|Thiolutin_17 	23643	25094	-	Loose	600	31.187	Streptomyces venezuelae rox	27.22	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAATTCTCCTGGCGTCTCCCAGAGCAGCTTTGACGTGGTCGTGGTCGGCAACGGGGCCCTGGGGCTTTCCCTCGGGCTCGTGCTGGCCCGCCGCGGGCAGACCGTCGCCGTGCTCGGGCAACCCCACCGCCCGATGGCGGGCTCCACCGCAGCCGGGGCCATGCTCGGCAGCTTCGCCGAGGTCACGACCTCGCTGGTGGCCAGCGAGGCCGGTCGGGCCAAGCTCGAACTCGGCATCCGGGCGACCTCCCTGTGGCCGGAGTGGCTCGCCGGGCTCGGCGACGACGCCGCCGAGCGGATCGTGACCGCGGACGGCACCACGGTCATTCTCAACGCGATCGGCATGGCCGAGATCGACGACACCAACTACCGGGCCATCCGCACCGAACTCGACCGCTACTCGGGCGCCTACGAGGACGTCGACCCGCTCGACCTCGAATGGGTCGACGCCGAGCCGATCTCCCGCCCGCTGCGGGCGTTCCACATTCCCGGCGAGCACGCGGTCAGCACGCCCGCGCTGCTGGAGCGGCTCCAGTCCGCATTCCTCGCCGAGGGCGGGACGGTCATCGCCCAACAGGCGACGCGGGTCGACCACGAGGGCGACCGGGTCACCGGCGTGACGCTGGAGAACGGCGACCGGCTCACCGCCGGGCAGGTCACCCTCGCGGCCGGCGCGCAGTCCCAGGCGCTGATCGACGGGCTGCCGGTGGCCGGCCGGATCCCGCCGCTGGTCAGCGGCTACGGCGTGTCGGTGCTGATGAAGACGGTCGACGGCACGGCCCCGCGCAGCGTCATCCGCACGCCCAACCGCTCCTTCGCCTGCGGCCTGCACGTCGTGCCGCGCGGCGAGGGCGAGGTCTACCTCGGCGCGACCAACGTCGTGTCGATCCGGCCGCGCGACGTCGCCGACATGCGCGACCTGGTGTTCCTGCTCCAGTGCGCGCACCGGCAGGTCCGCCGCAAGCTGTGGGACAGCCAGGTGGAGAAGGTCCAGGTCGGCAACCGGCCGATCGCGCTCGACGGCTTCCCGCTGATCGGCTCGGGCGGGATGGCCGGCCTGTGGCTGCTGACCGGCACCTACCGCGACGGCGTGCACCTGTCGCCGCTGCTGGCGCAGGAGATGGCCGACCGCATCCTGGGCGAGCCGGGCTCGGTGGACCTCGACCGGTTCACGCCGCTGCGCAAGCCGTTGCAGGAGTGGACCCGCGACCGCATCGTCAACGACACCGTCGAGCACTGGATCGGCATCGGCTACGAGCAGGACTGGCAGATCCCGGTCGACTGGCACCAGTGGATCGAGACCGACCTGCGGCCGGCGACCGAGCGCTGGGTCGAGGACATCGACCCCGAGTTCACGCCGCCCGCCGAGCTGGTCTTCCTGTCCCGGATGGACCCGGAGGCGCTGAAGCTGCTGCGCGAGTACTACGCCCGGACCCGCGAAGTCTGGTGA	MNSPGVSQSSFDVVVVGNGALGLSLGLVLARRGQTVAVLGQPHRPMAGSTAAGAMLGSFAEVTTSLVASEAGRAKLELGIRATSLWPEWLAGLGDDAAERIVTADGTTVILNAIGMAEIDDTNYRAIRTELDRYSGAYEDVDPLDLEWVDAEPISRPLRAFHIPGEHAVSTPALLERLQSAFLAEGGTVIAQQATRVDHEGDRVTGVTLENGDRLTAGQVTLAAGAQSQALIDGLPVAGRIPPLVSGYGVSVLMKTVDGTAPRSVIRTPNRSFACGLHVVPRGEGEVYLGATNVVSIRPRDVADMRDLVFLLQCAHRQVRRKLWDSQVEKVQVGNRPIALDGFPLIGSGGMAGLWLLTGTYRDGVHLSPLLAQEMADRILGEPGSVDLDRFTPLRKPLQEWTRDRIVNDTVEHWIGIGYEQDWQIPVDWHQWIETDLRPATERWVEDIDPEFTPPAELVFLSRMDPEALKLLREYYARTREVW	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	101.47	gnl|BL_ORD_ID|4833|hsp_num:0	5820			3	447	rifampin; rifaximin; rifapentine
BGC0001193.1|Thiolutin_18 # 25245 # 25832 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.701	BGC0001193.1|Thiolutin_18 	25245	25832	-	Loose	900	27.7202	smeC	30.56	3003053	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGGGAGTTCGAGGACATCAGCGGAGCCCTGTCCGACATCGGCCCCCGGCTGCGGCGGCTGCGCACCCAGCGCAGGCTCAGCCTGTCCGCGCTGTCGGAGATGACGGGGATCTCGAAGAGCACGTTGTCGCGACTGGAGGCCGGGCAGCGCCGCCCCAGCCTGGAGCTGCTGCTGCCGGTCGTGCGCGCCTACCGCATCCCGCTGGACGAGCTGATCGGCGGCCCGGAGGTGGCCGACCCGCGCATCCGCCCGACGCCGCGGCGGGTGGACGGCAGCGTGGTGCTCCCGCTGACCCGCCAACCCGGGCCGCAGCACACGTTCAAGACGATGATCCCGCCGTCGCGCAACATCCCCGAGCTGTGCACGCACGAGGGCTACGAGTGGCTCTACGTCCTGTCCGGCCGGCTGCGGCTGGTCGTGGCGGAGCAGGACCTGGTGCTCGAAGCGGGCGAGGCCGCCGAGTTCGACACCCGCCTGCCGCACTGGTTCGGCAGCACCGGGGAATGCCCCGTGGAAGTGCTGAACATCCTAGGACCACAGGGCGAGCGAATCCACTTGCGTGTACGGACAAACGAAGAGAAATAA	MREFEDISGALSDIGPRLRRLRTQRRLSLSALSEMTGISKSTLSRLEAGQRRPSLELLLPVVRAYRIPLDELIGGPEVADPRIRPTPRRVDGSVVLPLTRQPGPQHTFKTMIPPSRNIPELCTHEGYEWLYVLSGRLRLVVAEQDLVLEAGEAAEFDTRLPHWFGSTGECPVEVLNILGPQGERIHLRVRTNEEK	MKPMLLRALAAATMTTVLGGCVSMAPHYQRPEAPVPAQFGNAAIGAAEPALAMPAWRDVFLEPRLQQVIALALQNNRDLRVAVLQVEKERAQYRIQRAALLPSVDASGSVTRSRVSDANSETGVTQVTESDAVQVGISSWELDLFGRIRSLKNEALQNWLASAENQRAVRTSLVAEVATAWLALAADEQSLAFTQQTLDSQHQTLQRTEARHAQGLASGLDLSQVQTSVEAARGALAKLQAQQAQDRDALQLLVGAPLDPALLPTAQALDGSVALAPLPANLPSSVLLQRPDVLSAEHALQAANADIGAARAAFFPTLALTANYGHSSTALSTLFSAGTRGWSFAPSITAPIFHAGALKASLDASKIGKDIGIAQYEKAIQQAFSEVADALATRDHLTAQLDAQRALVADSQRSYTLADARYRTGLDGYLQSLDAQRSLYAAQQDLIALQQQEAGNRVTLFKVLGGGADAR	41.40	gnl|BL_ORD_ID|1160|hsp_num:0	1264			657	825	
BGC0001193.1|Thiolutin_19 # 25930 # 26871 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=8bp;gc_cont=0.765	BGC0001193.1|Thiolutin_19 	25930	26871	+	Loose	700	25.0238	tet(X4)	35.9	3004720	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGGGTGCCAACGGGAGCAGTGGGACCGACTGCGACGTGGTGGTGGTCGGCGGGGGAGCCGCGGGGCTGAGCGCCGCGCTGCTGCTGGTCAGGGCGCGGCGGCGGGTCGTCGTCGTCGACGGTTCGGAGCCGCGCAACGCGCCGGCCGCGCACGTGCAGGGCTTCCTGACCCGGGACGGCGTGGAGCCCACCGCGTTCCTGGAGGCGGGGCGGGCCGAGGTCACCGGGTACGGCGGTCGGATCGTCCGGGGCCTGGTGGACACCGCCGTGCCGCTCGACGGCGGGTTCGCCGTCCTGCTCGACGACGGCGACGCGCTGCGCGCCCGCCGGCTTGTCGTGGCCACCGGCCTGCGCGACGAGCTGCCCGGCATCCCCGGCGTCCGCGAGCGCTGGGGCCGCGACGTGCTGCACTGCCCGTACTGCCACGGCTACGAGGTCCGCGACCGGCCGGTCGGCGTGCTGGGCACCAGTCCGGGCGCGGTGTTCCACGCCCAGCTGGTCCGGCAGTGGAGCGACGACGTGGTGCTGTTCGCGCACACCCTCGACCTGTCCGACGAGGACCGGGTGCGCCTCGACGCCCGCGGCGTGCGGGTCGTGGAGGGGGTCGTGAGCCGGGTGCGGGTGGTCGACGACGTCCTGCGCGGCGTGGAGGTCGACGGCGAGGTGGTCGCCCGCGAGGCGGTGTTCGTCGTGCCGCGCATGGTGCCGCGCGACTCGCTGCTGACCGGCCTGGGCTGCGCCGTCGGCGAGGGCGGCTGGGTGACCGTCGACCGCTCGGGCCTGACCAGCGTGCCGGGCGTGTGGGCGGCCGGGAACGTGGTCGACCCGCGGGCGCTGGTCGTCACCTCGGCGGGGATGGGCTCGGCGGCCGGCTTCGCGGTGAACGTGGACCTGGTGGAGGAGGACGTGGCCGAGGCGATGGCGGTGGGCGCGGGCAGGTGA	MGANGSSGTDCDVVVVGGGAAGLSAALLLVRARRRVVVVDGSEPRNAPAAHVQGFLTRDGVEPTAFLEAGRAEVTGYGGRIVRGLVDTAVPLDGGFAVLLDDGDALRARRLVVATGLRDELPGIPGVRERWGRDVLHCPYCHGYEVRDRPVGVLGTSPGAVFHAQLVRQWSDDVVLFAHTLDLSDEDRVRLDARGVRVVEGVVSRVRVVDDVLRGVEVDGEVVAREAVFVVPRMVPRDSLLTGLGCAVGEGGWVTVDRSGLTSVPGVWAAGNVVDPRALVVTSAGMGSAAGFAVNVDLVEEDVAEAMAVGAGR	MSNKEKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHHPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIRVTSSFVGLATRIFPLGKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFIYGKEAQEESTQNEIEMFKPDFTFQQLLNV	81.30	gnl|BL_ORD_ID|2277|hsp_num:0	3402			33	150	tigecycline; tetracycline
BGC0001193.1|Thiolutin_20 # 26997 # 28592 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GAGGG;rbs_spacer=5bp;gc_cont=0.741	BGC0001193.1|Thiolutin_20 	26997	28592	-	Loose	1050	210.305	facT	34.99	3001313	protein homolog model	n/a	n/a	elfamycin antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAACCCGCGACAGGCCAACCCGTGGGCCGCGATCGGCGCGCTCTGCCTCGGCTTCTTCATGATCCTGCTGGACACGACGATCGTGTCCATCGCGGTGCCGGACATGCTGCGCGAGCTGGACGCCGGGTTGAACTCGGTGGTCTGGGTGATGAGCGTCTACCTGCTCACCTACGCCGTGCCGATGCTGTTCACCAGTCGGCTGGGCGACCGGTTCGGCCCCAAGCGGGTGTACCTGGCGGGCCTGGTGGTGTTCACCGCGTCGTCGCTGTGGTGCGGCCTGGCCGGCGACGTCGAAACCCTCATCGCGGCCCGCGCCGCGCAGGGCCTGGGCGCGGCGCTGATGACGCCCCAGACGCTGGCGTTCATCACCCACCTGTTCCCGCCCGCCGAGCGCGGCCCGGCCATGGGCCTGTGGGGCGGTGTCGCGGGCCTGGCGACGATCACCGGCCCCCTGCTGGGCGGCTTCCTGGTCGAGCACCTCGGCTGGGAGTGGATCTTCTTCGTCAACGTGCCGGTCGGCGCCGTCGCGGTCGTGGCGGCCCTGCTGCTGGTGCCCGACTGGCAGCCGCGCACCGCCCACTCCTTCGACCTGCCCGGCATCGCGCTGTCGGCGGCCGGGCTGTTCTGCGTGGTGTTCGGGCTGCAGAACGGCCAGCACTACGACTGGGGCGAGGTCGCCGGCGGGGTCACCGTGTTCGAGGTCGTCGGCGCGGGCGTGGCGCTGCTGGTCGCGTTCGTGCTCTGGCAGCGCCGCAACCGGCGGGAACCCCTGCTGCCGCTGGAGGTGTTCGGCAACCGCAACTTCTCCGCCGGCACGCTCACCGCCGTCACCGTCGGCTTCACGATGACCGGGATGTTCCTGCCGCTGATCATCTACATCCAGACGGTGCTGGGCCTGAGCCCCACCATGGCGGGCGTGCTGACGGCGCCGATGTCGCTGCTGTCGGGCGTCGTGTCGCCGTTCGTGGGGCGCGCCTCGGACCGGGTCGACGGCCGCCACCTGGTGGTGGCGGGCCTGGCGCTGCTGGCGGCGGGCATGGCCGTCATCGCGCTCCAGGCGCGGCCGGACACCAACCCGTGGGCGCTCGTCCCCGCGCTGCTGCTCAGCGGGTTGGGCATCGGCCTGGTGTTCCCGCCGATGAGCAACCTCACCATGAACGGCGTGGCGCCCCGGCTGGCGGGCGCGGCGTCGGGCATCTTCAACACCGCCCGCCAGGTCGGCGGCGTGCTGGGCAGCGCCGCGATCGGCGTGCTGCTGCAGGCCCGGATCAGCACGTCGACCGCGCACGAGGCGGCCGTCGCCGCCGAGCAGCTGCCCGAGCCCTACCGCGCCCCGTTCACCGCCGGCATCGCCGAGGCGGCGGCGGGCGCGGGCGAGTTCGGCGCGGAGAGCGGGCACGCGGACGTGTCCGGCCTGCCGCCGGAGGTGGCGCGGCAGGCGGGCCGGCTCGCCGCGCAGGCCGTCGAGGCGGGCCTGACCGACGCCGTGCGGGCCACGCTCCTGCTGCCCATCGCGGTGCTGCTGCTGGGGATCGTGGCCGCCCGCCTGCTGCGCCCGGTCACGCCGCGACCGGGGTCGGCCGAACGCGGGTGA	MNPRQANPWAAIGALCLGFFMILLDTTIVSIAVPDMLRELDAGLNSVVWVMSVYLLTYAVPMLFTSRLGDRFGPKRVYLAGLVVFTASSLWCGLAGDVETLIAARAAQGLGAALMTPQTLAFITHLFPPAERGPAMGLWGGVAGLATITGPLLGGFLVEHLGWEWIFFVNVPVGAVAVVAALLLVPDWQPRTAHSFDLPGIALSAAGLFCVVFGLQNGQHYDWGEVAGGVTVFEVVGAGVALLVAFVLWQRRNRREPLLPLEVFGNRNFSAGTLTAVTVGFTMTGMFLPLIIYIQTVLGLSPTMAGVLTAPMSLLSGVVSPFVGRASDRVDGRHLVVAGLALLAAGMAVIALQARPDTNPWALVPALLLSGLGIGLVFPPMSNLTMNGVAPRLAGAASGIFNTARQVGGVLGSAAIGVLLQARISTSTAHEAAVAAEQLPEPYRAPFTAGIAEAAAGAGEFGAESGHADVSGLPPEVARQAGRLAAQAVEAGLTDAVRATLLLPIAVLLLGIVAARLLRPVTPRPGSAERG	MNKAGQAEKPAAAGPPATPETPEPDPKRWLALTVLLVATFMDLLDANIITVAIPSIQRDLGASTFAIQAMTAGYTLSFAVLLITGGRLGDIFGRKRMFLVGVGGFVLASAMCAAAPSTDLLVVARALQGLTAAVMVPQVLALIHVSFAPQEIGRVVSLYASMVGLAIVSGPLIGGALISWNPLDLGWRSIFVVNLPVGVLALVGAAKWMRESSSPHAKRLDIAGMLLIVLGLLLLMVPLTLGRELDWPVWSIVSLVAAAPVLVLFVVYERHKTAKDGSPLVTLSLFKVRAFGAGIGVQLLFSAIPAGFFLSWTLYLQAGLGWSALHTGLTAIPFSLCVPIVGGLAVRRLSPLYGRYCLLAGAVLMLAGILSYAWAADRFGTDITSWHAIPSMLLIGSGMGMLMPPLTALVLREVQPQEAGAASGIINATGQLGAALGVAVIGSLFFAALAGNAGPQAERVAPTVQSVSPRQASDLRDCATEALGQDDLAKVPDICSTLVQGADDGTRDTINGALGEIRAKTFVSTYSETLYWAAGGLVPVTALVLLLPHHRVRREEPAQ	94.99	gnl|BL_ORD_ID|1345|hsp_num:0	1469			72	1371	factumycin
BGC0001193.1|Thiolutin_22 # 29514 # 31991 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGAGG;rbs_spacer=7bp;gc_cont=0.796	BGC0001193.1|Thiolutin_22 	29514	31991	+	Loose	725	28.1054	SRT-2	26.17	3002494	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	SRT beta-lactamase	ATGAGCACCCCCATCGAGGTGATCGACGCGGTGGCCGGCCCCGCCGACGACGACGGCCTCGGCTGCCTGCGCACCGAGCGGGGCAACCTGCCGCTGGAAGCGGTCGACGTGCGGGCCGCGATCACCGGCCTGGCGTCGCGGACCACGATCACCCAGACCTTCCGCAACCCGCACGGGCAGCCCCTCGAAGCGACCTACGTCTTCCCGCTGCCGTCCCGCTCGGCGGTGACCCGGCTGCGGATGGAGGCCGCCGGCCGGGTGGTCGAGGGCGTGCTCCGGGAGCGCGGCGAGGCGCGCGCCGACTACGACCGGGCCGTCGCCGGCGGCCGGCGCGCCGCCATCGCCGAGGAGGAGCGGCCGGGGGTGTTCACCACGCGGGTCGGCAACGTCCTGCCGGGGGAGCGGGTCACCGTCCGGCTGACGCTGGCCGGGGTGCTCGCCCACGAGGACGGCGCGGCGACCTACCGGCTGCCGCTGGTGGTCGCGCCCCGCTACGTCCCGGGCGCGCCGCTGGCGGGCGGGCAGGTCGGCGACGGCGTCGCCGCGGACACCGACGCGGTGCCGGACGCCTCGCGGATCAGCCCGCCGGTGCTGCTGCCGGGTTTCCCCGACCCGGTGCGGCTGTCGGTCGAGGTGGACGTCGACACCGCCGGCCTGCCACCCGCGACGCCCTCGGCGACCCTGCACGCGACCGTCGTGGAGCGGACCGGGAGCGGGTTCCGGGTCCGGGTCGAGCCGGGCGCCCGCGTGGACCGGGACTTCCTGCTGCGGCTGGCCTTCGCCGACGACGACGCGGTGCGCACGTCGCTGGCCGTGCGACCGGACGAGGACGGCCGCGCCGCGACGTTCGCGCTGACCGTCCTGCCGCCCGCCGCGCGGGTCCCGGCGCGCGGCCGGGACGTGGTGGTCGTCCTGGACCGCTCGGGCTCGATGCACGGGTGGAAGGTGGTGGCCGCCCGGCGCGCGGCGGGGCGGATCGTCGACAGCCTGGGTGCCGGTGACCGGTTCGCGGTCCTGGCGTTCGACGGTGTGGTCGAGACCCCGGTCGCCCTGCCCGCCGGCCTGGTCGGGGCGACCGACCGCAACCGCTACCGGGCGGTGGAGTTCCTGGCCGGCCTGGACGCCCGCGGCGGCACGGAGATGGCCGAGCCGCTGCGCCGCGCCGCCGGGCTGCTGGGCGCGGTGGAGGAGCGGGAGCGCGTGCTGGTCCTGGTGACCGACGGCCAGGTCGGCGACGAGGACCGGCTGCTGCGCGAGCTGGCGGGGCCGCTGTCCGGGGTGCGCGTGCACGCCGTCGGCGTCGACCGGGCGGTGAACGAGGCGTTCCTGCACCGGCTGGTCGGGTCGACGGGCCGCTGCGAGCTGGTCGAGTCGGAGGACCGGCTGGACGAGGTGATGCGCCGCGTGCACCACCGCGTCGGCGCGCCCGTCCTGACCGGCCTGGCGGTGCGGTCGGCGGGCCTGGCCGTGGACGAGGGGACGCTGACGCCGTGGCCGCTGCCCGACCTGTTCCCCGGCGCGCCGGTCGTCGTCCTCGGCCGCTGCGCCACCGGTGGCGGGGGCGGCGTGGAGCTGTCCGGCGCGGGCGGGTGGCGGCAGGAGGTGCCCGCGGTCGCGAGCGACAACCCGGCGCTGGCGGCGCTGTGGGCGCGCTCGCGCGTGCGCGACCTGGAGGACCGGTACGTGGTCGGCGAGGACGACCCGGCGGAGCTGGAGCGGCGGATCGTGGCGACGTCGCTGGAGTTCGGCGTGCTGTCGCGGTTCACGGCGTTCGTCGCGGTGGACCCGCGGGTGGTGGACGAGTCGGGCGAGCTCCACCGCGTGGTGCAGCCGGTGGAGCACCCCGACGGCTGGGGGACCCCCGCCGGCCCGCCCGCTCCCGCGCCGCTCGCCGGCGGGGTCGGCCCCGCGTTCGCGGCGGCCCCGGGGTTCGCCGCGCCGCCGGCCCCGGCGACGTCGTTCGCGCGCCGCCACTCCGCCCCGCACCGGGCGCGGTCGTCCGCCGACGCCGTGCCGCCGCCCGTGGCCCTGCCGCCGCCCGTGGCCCTGCCGCCGGCCGGCGCCGTGCCGCCGGCCGTGCCCTCGCCCGCTGTGCCCTCGCCCGCTGTGCCCCCGGCCGCCGCCCCGCCGCCCGCTGCGCCCCCGGCCGCGCCCGAAGCCGCCCCGGAACCGCTGTCCCGCTTCCTGACCCGCGAGTTGGACGCCCTGCGCCGCACGGCCCCGGCCGACGCCGTCGCGGCGCTGTCCCGGCTGGTCGCCGGGATCGAACGCCTGCACCCGGCCTGGACCGCCGCGGGCGAGCCCGCGGACCACGTGCGGGCGCTGCGGGACCTGGCGGCGGCCCTGTCCGCCGCCTTGCCCACGGCCCCGTCCGCAGCCCCGCCCACGACGACCGACCCGGCCCGCCGGCTGCGGGAGGCGATCACCGCGCTGGAGGGCCTGACCGCGCCGCGCCGCGGGTCGTTCTGGAAGCGCTGA	MSTPIEVIDAVAGPADDDGLGCLRTERGNLPLEAVDVRAAITGLASRTTITQTFRNPHGQPLEATYVFPLPSRSAVTRLRMEAAGRVVEGVLRERGEARADYDRAVAGGRRAAIAEEERPGVFTTRVGNVLPGERVTVRLTLAGVLAHEDGAATYRLPLVVAPRYVPGAPLAGGQVGDGVAADTDAVPDASRISPPVLLPGFPDPVRLSVEVDVDTAGLPPATPSATLHATVVERTGSGFRVRVEPGARVDRDFLLRLAFADDDAVRTSLAVRPDEDGRAATFALTVLPPAARVPARGRDVVVVLDRSGSMHGWKVVAARRAAGRIVDSLGAGDRFAVLAFDGVVETPVALPAGLVGATDRNRYRAVEFLAGLDARGGTEMAEPLRRAAGLLGAVEERERVLVLVTDGQVGDEDRLLRELAGPLSGVRVHAVGVDRAVNEAFLHRLVGSTGRCELVESEDRLDEVMRRVHHRVGAPVLTGLAVRSAGLAVDEGTLTPWPLPDLFPGAPVVVLGRCATGGGGGVELSGAGGWRQEVPAVASDNPALAALWARSRVRDLEDRYVVGEDDPAELERRIVATSLEFGVLSRFTAFVAVDPRVVDESGELHRVVQPVEHPDGWGTPAGPPAPAPLAGGVGPAFAAAPGFAAPPAPATSFARRHSAPHRARSSADAVPPPVALPPPVALPPAGAVPPAVPSPAVPSPAVPPAAAPPPAAPPAAPEAAPEPLSRFLTRELDALRRTAPADAVAALSRLVAGIERLHPAWTAAGEPADHVRALRDLAAALSAALPTAPSAAPPTTTDPARRLREAITALEGLTAPRRGSFWKR	MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYGVASKQTGKPITEETLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGVSLLNLATHTSGLPLFVPDDVTNDAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKSLDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIKSNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIEGNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFPNDDRVEAAYHIVQALEKR	218.25	gnl|BL_ORD_ID|1735|hsp_num:0	1878			792	1113	
BGC0001193.1|Thiolutin_23 # 32361 # 32558 # 1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.747	BGC0001193.1|Thiolutin_23 	32361	32558	+	Loose	400	23.483	Erm(39)	35.56	3000602	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGAGCCGGCCGCCGCTCGCGGGTGTCGGGGTCGCCGGGCCGCCGACGACCGATCGGACCAGCGCGCGGGCGTTCCGGGAGGTCCCCCGGGACCGGGTGGACCGGGCCGGGGGCACCGCCTCGGAAGGAGGCGGACCGGTCATTCCCGGTGCCCCTTCCCGCCACTCCAATGGAGCTAGACACCGTTGTTCCGGATAA	MSRPPLAGVGVAGPPTTDRTSARAFREVPRDRVDRAGGTASEGGGPVIPGAPSRHSNGARHRCSG	MSSVHHGRHENGQNFLRDRRVVGDIVRMVSHTAGPIVEIGAGDGALTLPLQRLGRPLTAIEIDLHRARRLADRTTAEVIATDFLRYRLPRTPHVVVGNLPFHLTTAILRRLLHENGWTDAILLVQWEVARRRAGVGGATMMTAQWWPWFEFGLARKVSADAFRPRPSVDAGLLTIQRRAEPLLPWADRRAYQALVHRVFTGRGRGLAQILRPHVHPRWLSANGIHPSALPRALTARQWVALFDAAG	26.42	gnl|BL_ORD_ID|1562|hsp_num:0	1701			465	594	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0001193.1|Thiolutin_24 # 32665 # 34125 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=8bp;gc_cont=0.778	BGC0001193.1|Thiolutin_24 	32665	34125	+	Loose	2200	26.9498	rpoB2	44.12	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGACAAAACCCGAAGCGGAACCGCTGGAACGCGCCGTCTGGCCCTCGCCGGTGGAGATGAACGCGCTGGAAACGCTGTTCTGGCGAGCGGACGACCACCCCGGGATGCGGTCGAACATGCTGGGCGTCGTCGTGCTCGACCGCTGCCCCGGGTGGGACCGGCTGGTGGCCAGGCACGAGTGGGCCACCCGCGTGGCCCCGCTGCTGCGCCACCGGGTCCTGGAGCCGCCGCTGCGGCTCGGTCGACCGTTCTGGGTGGTCGACCCCGCCTTCGACGTGCGCAACCACCTGCACCGGGTCCGCCTGCCGACGCCGGGCTCGACCGGCCTGCTGCTCGACCTGGCCCGGGACGTGGCCTCCGCGCCGTTCGCCCGGGAACGCCCGCTGTGGTCCGCGACGCTGGTGGAGGGCCTCGACGACGGCCGGGGCGGCGGCGCGGCCTACCTGCTCAAGCTGCACCACAGCCTCAGCGACGGGATCGGCGCGGCGCAGCTGGTCACCGTGCTGCTGGACCCCGCGGCCGAACCGCCGGCCGACCCGCTGCTGCCGCCCGCCCCCCGGCCGGGAGCCGCCTCGCCCGCCGCGCTGCTCGCCCGGCGCCTGGGCCGGCGGCTGGCCGCGCTGCCGCCGTCCGCCGTCCGGGCCGCGCGGCGCGCACGGGTCGCCCCGGGTGACGGCTCCGGCCGGGAGACCCGTCCGGCCGACCGGCTCACCGACCGGGTGCTCTCCTTCGCCCGCACGACGCTGGTGCCGCCGGTCCCGGCTTCGCCGCTGCTGCGCGAACGCAGCCGGGCCATGCGCTTCGACGCCCTGGAGGTCCCCGCGGAGGCGCTCAAGGCGGCGGGCCGGGCCGGCGGCGGCACGCTGAACGACGCCTTCGTGGCCGCCCTGATGGGCGCGTTCGAGCGCTACCACCGGGCGTTCGGGGTGGAACTGGCCGCCCTCCCGCTCGTCGTCCCGATCAGCGTGCGCGGGCGCGCGGACCTGCCGGCGGGCAACCGGCTGGCCAGCACGCGGCTGGCGATGCCGGTCGCGGGCCCGGGGCCGGCCGAGCGCGTCGCGGAGTCGCGCCGGCGGGTCGCGCGGGTGCGGACCCCGGCGACGCTGCGGGCGCTGGACCTGCTCAGCCGGCCGATCACCCCGTTGCCGGGGCCGCTGGTGCGGCTGGTGTTCACCGGCATGTTCCGCGGCAACGACCTGATCGCGACCAACTTCCGCGGCCTGCCCGGCGGGCTGTCCCTGGCGGGGGCGCGGGTCCTGGGGATCACGCCGTTCCCGCCGCTGCTGCGCGGCGCGACGAGCATCGCGCTGACCACCTACGGCGGGACGTGCCACATCGGGGCCACCCTCGACACCGGCGCGTTCACCGCGCCCGCCGCGTTCGCCGCCTGCCTGCGGGAGGGCTTCGCCGAAGTCCTCGCCCTGGCCCCGCGGCACGCCGCCACCCCGAGGACCGCGTGA	MTKPEAEPLERAVWPSPVEMNALETLFWRADDHPGMRSNMLGVVVLDRCPGWDRLVARHEWATRVAPLLRHRVLEPPLRLGRPFWVVDPAFDVRNHLHRVRLPTPGSTGLLLDLARDVASAPFARERPLWSATLVEGLDDGRGGGAAYLLKLHHSLSDGIGAAQLVTVLLDPAAEPPADPLLPPAPRPGAASPAALLARRLGRRLAALPPSAVRAARRARVAPGDGSGRETRPADRLTDRVLSFARTTLVPPVPASPLLRERSRAMRFDALEVPAEALKAAGRAGGGTLNDAFVAALMGAFERYHRAFGVELAALPLVVPISVRGRADLPAGNRLASTRLAMPVAGPGPAERVAESRRRVARVRTPATLRALDLLSRPITPLPGPLVRLVFTGMFRGNDLIATNFRGLPGGLSLAGARVLGITPFPPLLRGATSIALTTYGGTCHIGATLDTGAFTAPAAFAACLREGFAEVLALAPRHAATPRTA	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	41.82	gnl|BL_ORD_ID|2431|hsp_num:0	2831			2979	3081	rifampin; rifaximin; rifabutin; rifapentine
BGC0001193.1|Thiolutin_25 # 34160 # 34984 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.766	BGC0001193.1|Thiolutin_25 	34160	34984	+	Loose	500	34.2686	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid	25.64	3003393	protein variant model	V78A	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant inhA	ATGCCGTCCCCGCTCGACCTGTTCGACCTGAAGGGCAAGACAGCGCTCGTCACCGGGGCGTCCCGGGGGATCGGCCGGGCGATCGCGGTCGGGCTCGCCGCGGCCGGCGCCGACGTGGCGGTGCTGGCGCGGAGCACGACCGCGCTGGAGGAGGTGGCCGGGGAGGTCGAGGACCTCGGCCGCCGCGCGCTCGTGCTGACCTGCGACGTGACCGACGGCGAGCAGGTCCGGGCCGCGGCGGCGACCGCCCGGGCCGGGTTCGGCGACCCGGACGTGCTGGTCAACAACGCCGGGGGGATCGGCCACGCGGGACCGTTCCTCGACCTGGACCTCGCCGACTGGACGCACGTGCTGCGGCTGAACCTGGAGTCGGTGGTCCACGTCTGCCAGGTCTTCGGCCGGCGGCTGGTGGAGCGCGGCGGCGGCTCGGTCGTCAACGTCTCGTCCATCGCCGGGCTCGCGGGCACGCCGATGCTGGCCCACTACGCGGTGACCAAGGCGGCCCTCATCTCGCTCACCCGGACGCTGGCCGCCGAGTGGGCGCCGGCGGGCGTGCGGGTGAACGCCCTGGTGCCGGGGTGGGTCCGGACCGACCTGACCGAGGCGTTCCTCGCCGACCCGGACGCCGCGGCCGGGCTGCTCGCCGCCGTGCCCTCCGGCGCGTTCGGCAGCCCCGAGGACGTCGTCGGCGCGGTGGTCTACCTCGCGGGCGACGCCTCGCGCTCGGTCACCGGCGGCTGCCTGGTCGCCGACGGCGGCACGACCTGCTTCGTCGGCGGCCCGCAGATGCTCGGCTTCCTCCGGCACGGCCGCACCCCCGCCTGA	MPSPLDLFDLKGKTALVTGASRGIGRAIAVGLAAAGADVAVLARSTTALEEVAGEVEDLGRRALVLTCDVTDGEQVRAAAATARAGFGDPDVLVNNAGGIGHAGPFLDLDLADWTHVLRLNLESVVHVCQVFGRRLVERGGGSVVNVSSIAGLAGTPMLAHYAVTKAALISLTRTLAAEWAPAGVRVNALVPGWVRTDLTEAFLADPDAAAGLLAAVPSGAFGSPEDVVGAVVYLAGDASRSVTGGCLVADGGTTCFVGGPQMLGFLRHGRTPA	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL	101.86	gnl|BL_ORD_ID|1964|hsp_num:0	1574			12	588	isoniazid
BGC0001193.1|Thiolutin_26 # 35017 # 36606 # 1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=GAGGG;rbs_spacer=7bp;gc_cont=0.763	BGC0001193.1|Thiolutin_26 	35017	36606	+	Loose	450	26.9498	OXA-496	34.09	3005335	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGTCCGACCGCCCCGTTCTGCTGTTCCCCGGTCTCGGCGCCTGCTCCGCCGGGGTCCTCAGACAGGCCCGGCAGCACCACGCCGAGGTCGACGAGACGTTCGCGGAGATCGACCGCGCCGCCGCCCGGCTGGGCGTGCCGGCGGTGTCACCGGTCCTGTTCGCCGGCGCGCCGGTGTCGGTGCGGGACCTGCTCGCCGGACCGGCGGAGGTGGCGCAGCTCGCCGTCTTCGGCGTGTCGGTGGCCGTGCACCGGATCCTCGCCGCCCGGGGGGTGCGGCCCCGGCTGCTCGTCGGGCACAGCTTCGGCGAGATGGCGGCCCTGGTCGCGGCCGGGGCGTTCACGCTCGCGGACGGGGTGCGGCTGGTGTGCGCGCGGGCGGCGGCGCTGGAGCCGTGGGAGGGCCGCGGCGGGATGGCCGCGATCGGCCTGGACGAGGAGACCGCCGGCCACCTCGTGGGCGTGCTCGGGGACACCGACCTCGTCGTGGCGTGCCTGAACGCGCCCCGGCAGACGGTGCTGGCCGGCTCCCCGCCGGAGCTCGACCGCGCCGAACGGCTCGCCGCGGCGCTGGGCGTCCAGTTCGCCCGCCTGCACCTGCCTTACGCCTCGCACCACCCGTCGATGAGGGCTGCGGTGGGCGATTTCATGGCCCGGATGGCGAACGTGCGGCAGCAGCCGTTGCAGCAGCCGGTGTACTCACCGATCCACCGCCGCCACTACACCGATGACGACGACCTGCGCCTGGCCCTCGCCGAATGCCTGGTGCTGCCCGTGCGGTTCACCGACACCGTGCGGTGGTTGCACGCCAGGGGGTGCACGACGTTCATCGAGAGCGGGGCGCTCAACGCGTTGACCAAGTGCGTGCAGCAGACCGTGCCGGGGGTGCGCGTGTTCGCCCCGTTGCTCGACCCGGCGCGGGAGGACGCCGGGCTGCGCGCCGCGGCCGAGTCGGGCGGGCGCGCGGACCCGCTCCCGGACCCCTTGTCGCACAACGGCAACGGACAGGTGGGCACGCCGCCGACCGTCCCGGCTGCCCCGTGGCCGGTCCCGGTCGAGCCGCCGGCCCCGCTGTCGTCGGTCGCTCCCGCACCGCAGGCTGCCCTGCCGACGCCGTCCGCGCCGTCGCCCGCCACGTCGTCACCCGCCACGCCGTCGTTCGCCGCGCTGACGCCGTCCGCACCGCCGCCGTCCGCGCTGACGCCGGCCGAGTCGATGCCCGCCGAGCCGTCACCGTTCGCGCCGTCGCCCACCGGGTTGCCGGCGGTCGCGGTGGAGAGCCAGGTGGTCGGTGTCGTCGCCGAACCGCCCGCCGCCCCCTCCGCGCTCGCGGGGTGGGACCGGCCGCGGGTCGTCGCCGAGCTGCGCGAGCTGTACGCGCGGGCGCTGGAGTACCCGGCCGACCTGCTGACCGAGGACGCCCTGCTGGAAGCGGAACTGGGCGTCGACTCGCTGAAGCAGACCTCGCTGCTGACGAAGGTCGCCGCGCGGTTCGGGCTGCCCGACCGGGTGGCGGACCTGCCCGTGTGGGAGCTGCCGACGCTGGGCCGCATCGCCGACTACGTGACCGGTGCGGGGACGGCGCGGTGA	MSDRPVLLFPGLGACSAGVLRQARQHHAEVDETFAEIDRAAARLGVPAVSPVLFAGAPVSVRDLLAGPAEVAQLAVFGVSVAVHRILAARGVRPRLLVGHSFGEMAALVAAGAFTLADGVRLVCARAAALEPWEGRGGMAAIGLDEETAGHLVGVLGDTDLVVACLNAPRQTVLAGSPPELDRAERLAAALGVQFARLHLPYASHHPSMRAAVGDFMARMANVRQQPLQQPVYSPIHRRHYTDDDDLRLALAECLVLPVRFTDTVRWLHARGCTTFIESGALNALTKCVQQTVPGVRVFAPLLDPAREDAGLRAAAESGGRADPLPDPLSHNGNGQVGTPPTVPAAPWPVPVEPPAPLSSVAPAPQAALPTPSAPSPATSSPATPSFAALTPSAPPPSALTPAESMPAEPSPFAPSPTGLPAVAVESQVVGVVAEPPAAPSALAGWDRPRVVAELRELYARALEYPADLLTEDALLEAELGVDSLKQTSLLTKVAARFGLPDRVADLPVWELPTLGRIADYVTGAGTAR	MKILIFLPLLSCLSLTACSLPVSSSPSQITSTQSTQTIAQLFDQAQSSGVLGIQRGQQIQVYGNDLSRANTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFSAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSVLAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIVAFSLNMQMQNGIDPAIRLEILQQALGELGLYPKVGQQSK	189.61	gnl|BL_ORD_ID|3042|hsp_num:0	4067			21	153	cloxacillin; oxacillin; cefalotin
BGC0001193.1|Thiolutin_27 # 36603 # 39383 # 1 # ID=1_27;partial=01;start_type=GTG;rbs_motif=GGG;rbs_spacer=9bp;gc_cont=0.783	BGC0001193.1|Thiolutin_27 	36603	39383	+	Loose	400	108.612	Escherichia coli fabG mutations conferring resistance to triclosan	31.33	3004049	protein variant model	Y151V	G93A:2666, F203A:2666, F413L:1943, I21V:1574	disinfecting agents and antiseptics	antibiotic target alteration	antibiotic resistant fabG	GTGACGGGGGAGTTCGCGGGTCGCGTGGTCGTGGTGACCGGGGGCGCGCGCGGTGTGGGGCGGGCGATCACCGAGGCGTTCGCGCGGCGCGGCGCGCAGGTGGTGCTCAACTACTTCCACGCCACGGCCGAGGCGCCCCGGGTCGTCGCCGAGCTGACCGGCCGCGGCGCGTCGGTGTGGGCGGTGCGCGCCTCGGTCGCGGTGGCCGAGCAGGTCGACGCCCTGTTCGACGAGGTGGAACGCCGGTGCGGCGCGGTCGACGTGCTGGTGAACAACGCGGCCTCGGGCGCGCTGCTGCCGCTGGACCGGCTGCACGAGTCGCACTGGCAGCGGGCCGTGGACACCAACCTGCGCGGCGGCCTGCGGTGCGCCCGGCGGGCGGCGGCGCTGATGGCGCGGCGCGGGGGAGGCGCGATCGTCAACCTGTCCTCGGTCGGCAGCTCCCTGGTGATCGGCGACTACGCCGCCGTGGGCACCACGAAGGCGGCGGTCGAGGCGCTGACCCGCTACCTGGCCGTGGAGTTCGCCCCCGCCGGCATCCGGGTCAACACCGCGTCCGGCGGCCTGCTCGACGGCGCGGTGGCCGGCCTGTTCCCCGACGCCGCGCGGCTGGCCGAGCGGGTGCGCGCGGCGACCCCGCTGGGGCGCCGGCTGGGGCGGGAGGAGGAGCTGGCCGAGCTGGTGGTGTTCCTGGCCTCGCCCGCCGCGTCGTGGATCACCGGCCAGACGGTGGTCGCCGACGGCGGGCTGTCCCTGGGCTCCGCGATGCTGACCGCCCCGGACCGGGCGGACGCCACGCCGCCCCTGCTCCCCGCGACCCCGCCACCCCCGGACCCACCCCCCGCCCCGACAGGCCCGACGCCTCCCGCCGCGACTCCACCGGCCCCGCCTCTTCCCGACCCGGCCTCTCCTGCTCCGGCACCTTCTACCCCGACCCCACCGGTCGCGACTGCGCGGACCCCGCTCCCGCCGGCGTCGCCCACCCCGGAACCACCGCCGTCCGCCGCCGTGGTGCGCTCCGACGCCATGGAGGTGGCGGTGGTCGGTGTCGGCGTGGTGACCCCCGGCGCGAACGACCCCGAGGAGCTGTGGCGGGTCCTGTCCGAGGGCAGGAACGTGTTCCGCCGCCCCGTCCTGTTCGACGTCGAGTCCTTCCACTCCACCGATCCCGAGGCCGAGGACCGCACCTACTCCCCGGAATCCGGCTTCATCACCGGCTTCCGGCCCCACCCGCGCCTGGCGGCGGAGCTGGCCGAGGACCCGGCGCTCAGCCGCGAGGCCACCACGCTCTGGCTGCGCCACTGCCTGCACACGGCGCTGGACGGGGTGCGCGGGCACGCCCGCGGGCGCTGCTTCGCCGCGTTCGGCTACACCGCCGACGGCAGCCAGGACCTGGAGGGCCACCTGGTGCTGACCGGCTACCTCGACCGGCTGGCCGACCGGCTGCCCGCCGACGCCGCGCACCTGCTGCGCGCCCGCTACGACCGGCTCGGGCAGCCACCGCACGAGTTCCTGCCGCACCGGGTGGGCCGCAACGCCGTCGCGGGTCTGCTGCCCGCCGACACCGAGGTGGTCATGGTCGACACCGCCTGCTCCTCCTCGCTCTACGCCGTCGACCTGGGCGTGAAGGCGTTGCGGGAGGGCGCCGCCGACCTCGCCGTCTGCGGCGGCGCCTTCGCCTACAGCGCGCGCAACCTGGTGCTGTTCTCGAAGCTGCAAGGGCTTTCCCGCTCGGGCGTCGTGCGCTGCTTCGACCGCGCGGCGGACGGCGTGCTGTTCTCGGACGGCGCGGGCGTGGTGGTGCTCAAGCGGCTGGACCGCGCGCACGCCGACGGCGACCGGGTGCTCGGTGTCGTCGAGGGGATCGGGCTGGCCGGTGACGGCCGCGGCAAGGCCATCTACGCGCCCAACGCCGCGGGGCAGGCGCTGGCGCTGCGGCGGGCGCACGAGCGCGCCGGGGTCGCCGCGCCCGACCTCGGCTGGGTGATCGCCCACGCCACCGGCACCAGGGCGGGCGACAGCGCGGAGTTGGCGGCGCTGCGGGAGGTCGCCGGTCGGGGCGGGCCCGTGCCGCTGTCGTCCAACAAGGCCGTCGTCGGGCACACCGGCTGGGCGGCGGGCCTGGTCTCGGTGAGCCAGGCGCTGTCCGGGCTGGCGCGCGACGAGGCGCCCGCGCAGCCGTACCTGAGCGACCCCATCCCGGCCGTGGTCGGGAGCCGGTTCGCGCCGCCGACGGGCCGCGCCGCGCGGGGCATCCCCGCCGGCGGCGACGGGACGCGCCGGGTGGGCGTCTCGTCGTTCGGGTTCGGCGGCACGGACGCGCACCTGGTGCTGGCCGAGGACCGGCCCGGCCGGCGGCCGGCGGTCGGCGCGGCGAGGTCGGCGGAGGACGTGGTGGTCGTCGGCTGGGCCGCCGACCTGCCCGGCGGCGTCGACCCGGCCGCCTGGCTGCGCGGCGGCGAGCCGCCGGCCGCCGGGTTCGGCGAGCACCACCCGCTGCCGGGCCCCCGGGAGGTGGCGCTGCCGCCCGCCACGCTGCGCGGCATGGACCGCGCGCAGGTCATGGTGCTGCGCGCGGTGGCGGCGCTCACCGGCCCGGTCCGGGCCGCGCTGGCGGCCCTCCACGACACGACCGGCGTCGTCGTCGGGCACGCGGGGCCCACCCGCCGGGCGGTGCACCACGCGCTGCGGTGCTACCTGGGCGACCTCGACCGGGCGCTGGCGGGGCACACCGCCGCGGACGCCGGCCTCCGCGCCTCCCTGGACCGGCTGGGCGCCGAG	MTGEFAGRVVVVTGGARGVGRAITEAFARRGAQVVLNYFHATAEAPRVVAELTGRGASVWAVRASVAVAEQVDALFDEVERRCGAVDVLVNNAASGALLPLDRLHESHWQRAVDTNLRGGLRCARRAAALMARRGGGAIVNLSSVGSSLVIGDYAAVGTTKAAVEALTRYLAVEFAPAGIRVNTASGGLLDGAVAGLFPDAARLAERVRAATPLGRRLGREEELAELVVFLASPAASWITGQTVVADGGLSLGSAMLTAPDRADATPPLLPATPPPPDPPPAPTGPTPPAATPPAPPLPDPASPAPAPSTPTPPVATARTPLPPASPTPEPPPSAAVVRSDAMEVAVVGVGVVTPGANDPEELWRVLSEGRNVFRRPVLFDVESFHSTDPEAEDRTYSPESGFITGFRPHPRLAAELAEDPALSREATTLWLRHCLHTALDGVRGHARGRCFAAFGYTADGSQDLEGHLVLTGYLDRLADRLPADAAHLLRARYDRLGQPPHEFLPHRVGRNAVAGLLPADTEVVMVDTACSSSLYAVDLGVKALREGAADLAVCGGAFAYSARNLVLFSKLQGLSRSGVVRCFDRAADGVLFSDGAGVVVLKRLDRAHADGDRVLGVVEGIGLAGDGRGKAIYAPNAAGQALALRRAHERAGVAAPDLGWVIAHATGTRAGDSAELAALREVAGRGGPVPLSSNKAVVGHTGWAAGLVSVSQALSGLARDEAPAQPYLSDPIPAVVGSRFAPPTGRAARGIPAGGDGTRRVGVSSFGFGGTDAHLVLAEDRPGRRPAVGAARSAEDVVVVGWAADLPGGVDPAAWLRGGEPPAAGFGEHHPLPGPREVALPPATLRGMDRAQVMVLRAVAALTGPVRAALAALHDTTGVVVGHAGPTRRAVHHALRCYLGDLDRALAGHTAADAGLRASLDRLGAE	MNFEGKIALVTGASRGIGRAIAETLAARGAKVIGTATSENGAQAISDYLGANGKGLMLNVTDPASIESVLEKIRAEFGEVDILVNNAGITRDNLLMRMKDEEWNDIIETNLSSVFRLSKAVMRAMMKKRHGRIITIGSVVGTMGNGGQANYAAAKAGLIGFSKSLAREVASRGITVNVVAPGFIETDMTRALSDDQRAGILAQVPAGRLGGAQEIANAVAFLASDEAAYITGETLHVNGGMYMV	379.92	gnl|BL_ORD_ID|4713|hsp_num:0	2681			6	729	triclosan
